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Introduction  
History of OneWorld Community Health Centers, Inc.  
OneWorld Community Health Centers, Inc. is a Federally Qualified Health Center 
(FQHC) in South Omaha that provides affordable health care to the Omaha area’s 
vulnerable and underserved populations (One World, 2016). To better understand how 
this health center functions, it is important to consider the history of South Omaha. 
Specifically, there are two major events which began to attract immigrants to the South 
Omaha area. The first major event came after the passage of the Pacific Railroad Act in 
1862 (Dillon, Burger & Shortridge, 2007). This act established Omaha as the eastern 
terminus of the transcontinental railroad. The second major event was the development 
of the Omaha Stockyards and associated meat-packing industries which opened along 
the railroads in the 1870s and 1880s (Dillon, Burger & Shortridge, 2007).  Both events 
created more demand for immigrant labor and resulted in South Omaha being resettled 
by people from Mexico and other Latin American countries.  In 1955, Omaha surpassed 
Chicago and Kansas City and became the largest livestock market and meatpacking 
center in the nation (Dillon, Burger & Shortridge, 2007).  However, in the late 1960s 
many of Omaha’s major meatpacking plants began to move to more rural parts of 
Nebraska, and this had a significant impact on the Latino and Native American 
communities. These communities were financially dependent through employment on 
the meatpacking industry and therefore when it became inaccessible to them they were 
faced with reduced income and consequent difficulties of having access to health care.  
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In response to this need, various organizations in the Omaha area collaborated 
and established the Indian-Chicano Health Center in 1970 (OneWorld, 2016). Initially 
this clinic was staffed by volunteer physicians and students and provided dental and 
medical services in the evenings. Slowly the clinic began to grow and expanded the 
types of services being offered. In 2001, the Indian-Chicano Health Center received its 
designation as a Federally Qualified Health Center (FQHC) and in 2003 it was renamed 
to OneWorld Community Health Centers, Inc. In 2005, OneWorld moved its 
headquarters to Omaha’s historic Livestock Exchange Building, where it all started back 
in the 1960s.  
Mission and patient population of OneWorld Community Health Centers, Inc. 
The mission of OneWorld Community Health Centers, Inc. is to provide quality 
health care with respect to diverse cultures and attend to the needs of the underserved 
(One World, 2016). In 2016, One World cared for 37,771 patients, with 73.0 % of these 
patients being of Hispanic or Latino origin (Health Resources & Services Administration 
[HRSA], 2016). More than 60.7 % of patients seen at OneWorld are at or below 100 % 
poverty line and 49 % are uninsured. From the patients that are uninsured it is 
estimated that 28.2 % are children (age 0-17 years). Patients visiting OneWorld have 
access and utilize many services including adult medicine, behavioral health, dental, 
pediatrics, pharmacy, prenatal, quick sick urgent care, and women’s health (OneWorld, 
2016).  
Latino communities in the United States and Nebraska 
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In 2014, the U.S. Census Bureau estimated that there were approximately 55.4 
million Latinos living in the United States, comprising 17.4 % of the total US population 
(Siegel et al., 2015). These estimates make the Latino population the largest 
racial/ethnic minority group in the United States. Nebraska is no exception to this 
statistic, and the Latino population size is estimated at 167,000 which represents a 70 
% increase in population size from 2000 to 2010 (Ramos et al., 2013). The term 
Hispanic or Latino has been extensively used to describe any person that is of Mexican, 
Cuban, Puerto Rican, South or Central American, Dominican, or other Spanish descent 
(Ennis, Rios-Vargas, & Albert, 2011). In Nebraska it is estimated that 75 % of Latinos 
are of Mexican origin followed by Latinos from Central America and South America 
(Ramos et al., 2013). As the Latino population continues to increase in population size, 
it will be important to address the disproportionate burden of disease and death that 
this population group experiences. 
Health literacy among Latinos 
 The CDC defines health literacy as the degree to which individuals can obtain, 
process, and understand basic health information and services needed to make 
appropriate health decisions (CDC, 2016). The National Center for Educational Statistics 
(NCES) assessed health literacy in more than 19,000 adults in the U.S. by delivering the 
National Assessment of Adult Literacy (NAAL). In their final report they found that 
Hispanic adults had lower average health literacy than adults in any other racial/ethnic 
group (Kutner, Greenburg, Jin, & Paulsen, 2006). On a health literacy scale from 0 to 
500, Whites had the highest average health literacy score at 256 while Hispanics had 
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the lowest average health literacy score at 197 (Kutner et al., 2006). This may be due 
to difficulties in getting access to health information and being able to process it due to 
cultural and language barriers.  
Burden of Colorectal cancer in the United States and Nebraska 
CRC ranks as the third most commonly diagnosed cancer in both men and 
women (Alteri, Kramer, & Simpson, 2014; Siegel, DeSantis, & Jemal, 2014). 
Approximately 4.6% of men (1 in 22) and 4.2% of women (1 in 24) will be diagnosed 
with CRC in their lifetime (Siegel, Miller, & Jemal, 2016). The American Cancer Society 
(ACS) estimates that in 2017 there will be 95,520 new cases of colon cancer and 39,910 
new cases of rectal cancer diagnosed in the United States (ACS, 2017). Most of these 
cases will develop among older individuals given that the median age for colon cancer 
diagnosis is 68 in men and 72 in women (ACS, 2017). Additionally, the median age for 
rectal cancer diagnosis is 63 in both men and women (ACS, 2017).  
According to a 2012 Morbidity and Mortality Weekly Report (MMWR), it is 
estimated that 65% of U.S. adults aged fifty years of age or older were up-to-date with 
CRC screening. However, the screening rates in Nebraska were 60.9 % which is much 
lower than the national average. Furthermore, from 2004 to 2008 the colorectal cancer 
incidence rate was 65.4 per 100,000 for Nebraska males and 47.0 per 100,000 for 
Nebraska females (Nebraska Department of Health and Human Services [NDHHS], 
2011). The Nebraska incidence rates were higher than the US rate of 55.7 per 100,000 
for males and 41.4 per 100,000 for females (NDHHS, 2011). During this same time 
period the colorectal cancer mortality rate was 22.9 per 100,000 for Nebraska males 
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and 15.6 per 100,000 for Nebraska females (NDHHS, 2011). The mortality rate was also 
higher for Nebraska compared to the 21.2 per 100,000 for males and 14.9 per 100,000 
for females (NDHHS, 2011). Furthermore, during the period of 2010 to 2014 there was 
an estimated 4,550 Nebraska residents who were diagnosed with colorectal cancer 
while 1,714 Nebraska residents died due to colorectal cancer and associated 
complications (NDHHS, 2017). For Nebraska residents, it is estimated that at time of 
diagnosis 3 percent of cases were in situ, 38 % were local, 35 % were regional, 17 % 
were distant, and 7 % were unstaged (NDHHS, 2017).  
It is estimated that 27,150 men and 23,110 women will die from colorectal 
cancer in 2017 (ACS, 2017). However, racial and ethnic minorities are more likely to 
develop and die from cancer when compared to the general population. In 2015, it was 
reported that 22 % of deaths were due to cancer and 20% of deaths were due to heart 
disease for Latinos (Barrera et al., 2015). For non-Latino whites, it was reported that 24 
% of deaths were due to heart disease and 23 % of deaths were due to cancer 
(Barrera et al., 2015). This population is being affected by a cancer health disparity, 
defined by the National Cancer Institute (NCI) as ‘adverse differences in cancer 
incidence, cancer prevalence, cancer mortality, cancer survivorship, and burden of 
cancer or related health conditions that exist among specific population groups in the 
United States’ (NCI, 2008). In Nebraska, the top five causes of death for Latinos are 
cancer (18.6%), heart disease (14.9%), unintentional injury (13.9%), diabetes (4.6%), 
and stroke (4.6%) (Ramos, 2013). Among these cancers, CRC is the second-leading 
cause of cancer deaths for Latinos in the United States when males and females are 
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combined (National Colorectal Cancer Roundtable [NCCRT], 2016) One factor that may 
be contributing to CRC deaths is the low rates of CRC screening, which have been 
shown to decrease incidence, improve survival and mortality (Lai et al., 2016; Mandel et 
al., 1993; Sineshaw, Robbins & Jemal, 2014).  
Screening tests for colorectal cancer  
There are two main categories for screening tests that can be used to detect 
colorectal cancer. The first category consists of tests that can find both colorectal 
polyps and cancer, such as a colonoscopy. While the second category of tests are those 
that mainly find cancer, such as fecal occult blood test (FOBT) and fecal 
immunochemical test (FIT). FOBT and FIT have low to moderate sensitivity, however, 
these tests are low cost, can be performed at home, and are noninvasive. Furthermore, 
large randomized controlled trials have demonstrated that these two CRC screening 
tests can decrease CRC mortality by up to 33 % (Shaukat et al., 2013; Levin & Corley, 
2013; Mandel et al., 1993; Hardcastle et al., 1996; Kronborg O et al., 1996). Some 
limitations of these two screening tests are that they need to be repeated on an annual 
basis, FOBT requires dietary restrictions, FIT vary in sensitivity and specificity, both test 
will miss most polyps, and both can produce false-positive test results (ACS, 2017). 
Colonoscopies have high sensitivity and specificity, can examine the entire colon, are 
performed once every ten years, and allow for biopsy and removal of polyps (ACS, 
2017). Additionally, the National Polyp Study provided evidence for the long-term 
effectiveness of a colonoscopy. In this study it was discovered that patients who 
removed adenomas through colonoscopy had a 53 % reduction in mortality from colon 
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cancer over a median of 15.8 years (Zauber, 2012). However, some limitations of a 
colonoscopy are that it requires an orally administered bowel preparation, can be 
expensive, patients may see a colonoscopy as an invasive procedure (Young & 
Womeldorph, 2013), and it requires a minimum of two days.  
In 2005, the CDC initiated the Colorectal Cancer Screening Demonstration 
Program (CRCSDP) to explore the feasibility of establishing a national CRC screening 
program for underserved populations. One of the selected sites was the Nebraska 
Department of Health and Human Services (NDHHS). In Nebraska, the selected primary 
screening test was FOBT for individuals at average risk and colonoscopy for individuals 
for above-average risk (Tangka, Subramanian, Beebe, Hoover, Royalty, & Seeff, 2013). 
This program found that the average clinical cost per patient was $49 for FOBT 
(including costs for screening, diagnosis, initial surveillance, office visits, and associated 
clinical services) while the average clinical cost per patient was $842 for colonoscopy 
(including costs for screening, diagnosis, initial surveillance, office visits, and associated 
clinical services) (Tangka et al., 2016). In comparison, a study by Lang et al. (2009), 
provided detailed estimates of lifetime and phase-specific CRC treatment costs. This 
study, which included 56,838 CRC patients, found that the lifetime cancer-related health 
care costs per year of survival varied by stage of colorectal cancer (Lang et al., 2009).  
Patients with stage 0 CRC spent an excess of $3,210 per year, stage I patients spent an 
excess of $4,238 per year, stage II patients spent $6,723 per year, stage III patients 
spent an excess of $10,516 per year, and finally stage IV patients spent an excess of 
$30,794 per year (Lang et al., 2009). The excess costs associated with the treatment 
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and management of CRC highlight the importance of interventions aimed at the 
prevention and early detection of CRC.  
Knowledge and awareness of colorectal cancer and screening 
Using data from the National Health Interview Survey, a study found that in 2010 
the CRC screening was 58.6%, below the Healthy People 2020 target of 70.5% 
(Joseph, King, Miller, Richardson, & CDC, 2012). Multiple studies have examined 
knowledge of cancer among Latino women, and have found that Latino women have 
the lowest knowledge of cancer screening guidelines and lowest screening rates of any 
ethnic group (Borders, Warner, & Sutkin, 2003; Ramirez et al., 2000; Suarez et al., 
1994). Similarly, a study by Coronado and Thompson (2000), found that Latino men 
were more likely to have limited knowledge about the causes of cancer and the need 
for prevention practices than their non-Latino counterparts.  
Perception and attitudes on colorectal cancer and screening 
The ACS explored perceptions about CRC and screening through focus groups. 
Some perceptions included that Latinos are less likely to follow physician’s 
recommendations if there is a lack of trust, view cancer screening logistics as a barrier, 
view cancer as a strong source of fear, and have minimal awareness and knowledge 
about CRC and screening tests (ACS, 2017). Additionally, a study by Walsh et al., 
(2004), found that Latinos have misperceptions and erroneous understandings of CRC 
and screening. Specifically, Latinos were more likely to find FOBT embarrassing and 
that Latinos did not see the need to get screened if they were feeling healthy, when 
Gonzales  9 
 
compared to non-Hispanic whites (Walsh et al., 2004). An additional study also 
identified that embarrassment was a factor that was preventing Latinos from 
undergoing colorectal cancer screening (Fernandez et al., 2008). Another mentioned 
potential cause of colorectal cancer was the consumption of “bad food” (Goldman, Diaz, 
& Kim, 2009). Some participants mentioned that foods high in fat or hot spices can 
increase the potential in colorectal cancer (Goldman, Diaz, & Kim, 2009).  Lastly, 
various studies indicated that unscreened Latino patients mentioned that they had not 
undergone screening because it has never been mentioned or suggested to them by 
medical or public health professionals (Cameron et al., 2007).  
Barriers on colorectal cancer screening  
The ACS has identified many barriers on CRC screening. The first barrier is that 
Latinos view cancer screening logistics as a barrier (Green et al., 2008; Fernandez et 
al., 2008; Percac-Lima et al., 2009; Walsh et al., 2004). For example, participants in the 
ACS focus group mentioned that they tend to procrastinate or miss their appointments 
because the importance of screening is not understood. A second barrier is that Latinos 
view cancer as a strong source of fear (Fernandez et al., 2008; Goodman et al., 2006; 
Jandorf et al., 2010). Participants mentioned that there is a fear of the procedure, the 
preparation process, and the pain that is associated with some CRC screening 
procedures. A third barrier is affordability, and it has been noted that many Latinos 
have a low income or lack health insurance (Fernandez et al., 2008; Goodman et al., 
2006). A fourth barrier is machismo or considering CRC as embarrassing, and this can 
dictate whether Latinos are willing to engage in a CRC screening procedure (Walsh et 
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al., 2004; Goodman et al., 2006). The fifth barrier that has been identified by the ACS 
relates to limited knowledge that CRC screening can prevent CRC (Walsh et al., 2004; 
Fernandez et al., 2008; Goodman et al., 2006). The final major barrier is that doctors 
are not explaining the need for screening effectively, and this may be due to lack of 
connection with the patients, doctors’ underestimation of health literacy-related 
barriers, or doctors’ lack of emphasis on the importance of CRC screening (Walsh et al., 
2004; Fernandez et al., 2008; Jandorff et al., 2010).  
Significance of assessing awareness and attitudes of the Latino community in 
Omaha on CRC and screening 
Currently, OneWorld primarily utilizes fecal occult blood tests (FOBTs) and 
colonoscopies to detect early colorectal cancer in the early stages or the presence of 
any polyps. However, a qualitative study showed that patients with low health literacy 
had poor knowledge of CRC and screening terminology terms such as “FOBT,” 
“colonoscopy,” and “polyp”, which may negatively impact colorectal cancer screening 
rates for these patients (Davis et al., 2001). This is especially true for Federally 
Qualified Health Centers (FQHCs) who have reported low CRC screening rates. 
Nationally, it was reported that the CRC screening rates at FQHCs were 34.5% in 2014, 
38.3% in 2015, and 39.9% in 2016 (NCCRT, 2017). OneWorld has higher than average 
CRC screening rates which were 40.2 % in 2014, 46.2 % in 2015, and 47.4 % in 2016 
(HRSA, 2016). These low levels of knowledge and screening are concerning, and 
multiple studies have reported that Latinos are more likely to be diagnosed with CRC at 
a later stage (Vidal et al., 2009; Howe et al., 2006; ACS, 2007). The 5-year survival rate 
for Latinos decreases from 90.1% when diagnosed at a localized state, to 69.2% when 
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diagnosed at a regional stage, and 11.7% when diagnosed at a distant stage (Siegel et 
al., 2012).  
Conceptual framework 
The conceptual framework that is guiding this study is summarized in Figure 1. 
This is the same conceptual framework that was utilized by Partin et al. (2010) and it 
draws insight from the Health Belief Model (HBM), the Theory of Planned Behavior 
(TPB), and the Social Cognitive Theory (SCT). Through the combination of these three 
theories we are assuming that screening adherence is determined by background 
factors such as demographics and health characteristics; environmental factors such as 
social influence and physician recommendation for screening; and cognitive factors such 
as beliefs about outcomes associated with CRC screening, perceptions about one’s 
ability to undergo CRC screening, and knowledge of screening and importance. 
Screening adherence can directly be influenced by environmental factors and cognitive 
factors. Finally, background factors can indirectly influence adherence through their 
association with environmental and cognitive factors. This study focuses on the 
cognitive factors influencing screening with the hope that future interventions can be 
developed based on the results to improve CRC screening among the Latino community 
in Omaha. 
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Methods:  
Research Question  
This work addresses the current knowledge, awareness, perception, attitudes, 
and barriers to colorectal cancer screening among the Latino population receiving 
health services at the One World Community Health Center in South Omaha, Nebraska. 
Study Design 
This was a cross-sectional study. It was conducted between June 2017 – October 
2017 at the OneWorld Community Health Centers in South Omaha, Nebraska. 
OneWorld in South Omaha is a federally qualified health center (FQHC) that serves a 
predominantly Hispanic/Latino community. All study procedures were approved by the 
University of Nebraska Medical Center Institutional Review Board (IRB # 303-17-EX). 
Eligibility Criteria 
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 There were two eligibility criteria that a participant had to meet in order to be 
eligible for this study: (1) Be at least 30 years of age and (2) be of Hispanic or Latino 
origin (Mexican, Mexican-American, Puerto Rican, Cuban, Central American, South 
American, and of other Latino, Hispanic, or Spanish origin).  
Study Population 
The study population for this project included 150 individuals over 30 years of 
age that are of Latino or Hispanic descent receiving health services at the One World 
Community Health Center in South Omaha, Nebraska. This sample size was calculated 
based on a 2005 study that found that 1.1% of the general population indicated that 
they had a “very high chance” of developing colon cancer in the future (Cantor et al., 
2005). We assumed a similar proportion for the Latino community in South Omaha and 
found that a sample size of 300 produced a two-sided 95% confidence interval (CI) 
with a width equal to 0.028 when the sample proportion is 0.011. However, due to the 
difficulty of recruiting participants in this study and the limited amount of time we 
decided that a sample size of 150 would be sufficient. Samples of 150 produce a two-
sided 95% CI with a width equal to 0.043.  
Assessment tool 
A structured survey was developed consisting of 60 questions to collect 
information about colorectal cancer and colorectal cancer screening among 
Hispanics/Latinos in Omaha. This survey included validated questions about 
demographics, medical history, knowledge and awareness on colorectal cancer and 
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screening tests, perceptions and attitudes on colorectal cancer and screening tests, and 
barriers on colorectal cancer screening. Questions regarding demographics and medical 
history were retrieved from the 2016 Behavioral Risk Factor Surveillance System 
Questionnaire (BRFSS) (Centers for Disease Control and Prevention [CDC], 2015). 
Questions regarding knowledge and awareness on colorectal cancer and screening 
tests, perceptions and attitudes on colorectal cancer and screening tests, and barriers 
on colorectal cancer screening were retrieved from a national patient survey of 
colorectal cancer screening behavior known as the Survey of Colorectal Cancer 
Educational and Environmental Needs (SCREEN). This survey has been used in a 
previous research study by Partin et al. (2010), and different sections of this survey 
have been evaluated by other researchers. The survey was developed in English and 
then translated into Spanish by a University of Nebraska Medical Center College of 
Public Health faculty member fluent in this language. Following the translation of the 
survey into Spanish, the survey was then back-translated into English by a graduate 
student from the University of Nebraska at Omaha. These steps were taken to 
accommodate to the needs of the participants and to ensure validity of the translation.  
Barriers on colorectal cancer and screening 
 In total there were 26 questions regarding barriers on CRC and screening. These 
questions were asked through a five-point version of the Likert Scale, which allowed 
respondents to indicate if they Strongly Agree, Agree, Neither Agree nor Disagree, 
Disagree, or Strongly Disagree with a question. We scored the five-point Likert Scale by 
assigning a value of 5 for Strongly Agree, a value of 4 for Agree, a value of 3 for 
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Neither Agree nor Disagree, a value of 2 for Disagree, and a value of 1 for Strongly 
disagree. Due to the format of these questions there were four questions that were 
reverse coded for the analyses. From these 26 questions only 25 were utilized in the 
analyses. The 25 questions were grouped into the two different types of factors: 
cognitive factors or environmental factors as seen in Figure 2. To further divide these 
factors, we created six different categories for cognitive factors and the environmental 
factor remained with one category.  
 
Figure 3 reports the different questions that are found in the six different 
categories for cognitive factors and the one category for environmental factor. We 
Fig 2. Layout of questions regarding barriers on colorectal cancer and screening 
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defined the categories of cognitive factors and the category of environmental factor as 
it has been previously defined by Vernon, Myers, and Tilley (1997). In their study they 
utilized the following definitions: Salience and coherence: perceptions about the 
technical effectiveness, practical convenience, personal benefit, and whether the 
behavior is actively encouraged by significant others. Perceived Susceptibility: 
subjective personal risk of developing colorectal cancer or polyps. Worries and Fears: 
perceived negative components of consequences of undertaking and completing the 
behavior. Efficacy of Screening: perceived positive components or consequences of 
undertaking and completing the behavior. Self-efficacy: an individual’s belief in their 
capacity to execute a behavior and Social Influence: role of social norms and interaction 
with members of one’s social network (Vernon et al., 1997). Knowledge was defined as 
the familiarity with CRC screening principles and screening guidelines (Vernon et al., 
1997).  
 
Cognitive 
factors 
Questions 
Salience 1. Doing colon cancer makes sense to me. 
2. I think the benefits of colon cancer testing outweigh any difficulty I might have  
     in going through the test.  
3. Going through colon cancer testing is an important thing for me to do. 
4. I believe that having colon cancer testing can help to protect my health. 
Fears 1. I am afraid of having an abnormal test result. ⱡ 
2. I am worried that testing will show that I have colon cancer. ⱡ 
3. I am bothered by the possibility that testing might be physically uncomfortable. ⱡ 
Susceptibility 1. I believe the chance I might develop colon cancer is high.  
2. I think it is very likely that I will develop colon cancer.  
3. I believe that the chance that I will develop polyps is high.  
4. I think that compared to other persons my age, I am at lower risk for colon cancer.  
Screening efficacy 1. I think that when colon polyps are found and removed, colon cancer can be   
     prevented. 
Fig 3. Questions included in the cognitive factors and environmental factors affecting colorectal cancer and screening  
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2. I believe that when colon cancer is found early, it can be cured. 
Self-efficacy 1. Arranging my schedule to go through colon cancer testing is an easy thing to do.  
2. Finding time to go through colon cancer testing would be difficult for me to do. 
3. Going through colon cancer testing would be difficult for me to do. ⱡ 
4. I think that going through colon cancer testing would be an easy thing for me to do. 
Knowledge 1. I believe that colon cancer is mainly a problem for men.  
2. I believe that a person could have colon cancer but not have any symptoms.  
3. I think that getting checked regularly for colon cancer increases the chances of finding   
    cancer when it’s easy to treat.  
Environmental 
factor 
Questions 
Social influence 1. I want to do what members of my immediate family think I should do about colon 
cancer testing. 
2. Members of my immediate family think I should go through colon cancer testing.  
3. My doctor or health professional thinks I should have colon cancer testing.  
4. I want to do what my doctor or health professional thinks I should do about colon 
cancer testing.  
ⱡ indicates question was reverse coded when calculating the mean 
Participant Recruitment  
OneWorld patients were recruited by setting up a table in the main lobby of the 
OneWorld Community Health Centers Livestock Exchange Building. Interested 
individuals that met the inclusion criteria were eligible to complete the survey. The 
paper-based survey was delivered to each participant by a face-to-face interview, and 
each question was read verbatim. Surveys were completed in either English or Spanish 
based on the participants preferred language. After an individual had successfully 
completed a survey they were given a five-dollar gift card as a sign of appreciation for 
the participants’ time to fill out the survey.  
Data analysis 
Gonzales  18 
 
Data was transferred from questionnaires to an Excel file. SAS 9.4 was used to 
analyze the data. Descriptive analysis of the data included frequency and percentages 
for categorical variables and means and standard deviations for continuous variables. 
Comparisons of survey results by demographic variables were performed (e.g. gender 
or age).  Associations were examined between questions pertaining to demographics, 
medical history, knowledge and awareness, perceptions and attitudes, and barriers. 
Specifically, we examined if there are any factors that increase or decrease knowledge 
and awareness, affect awareness and attitudes, or contribute to barriers to colorectal 
cancer screening. This study included the use of Kruskal-Wallis test, Mann-Whitney test, 
and Chi-square tests. A Kruskal-Wallis test was used to determine if there were any 
statistically significant differences between two or more groups regarding barriers to 
colorectal cancer and colorectal cancer screening. The Mann-Whitney test was used as 
an alternative to the t-test, specifically when the variable in question is not normally 
distributed in the two or more groups. A Chi-square was used to examine any type of 
relationship between two or more categorical variables. The Fisher’s exact test was 
used as an alternative to the Chi-square test when one or more of the categorical 
variables have a small expected frequency. A significance level of 0.05 was used for all 
statistical tests.   
Results  
Demographics 
The demographic information of study participants is summarized in Table 1. In 
total, there were 150 eligible subjects who responded to the survey. The mean age of 
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participants was 44.5 years old with a minimum age of 30 years old and a maximum 
age of 79 years old. When participants were divided into three categories, according to 
age groups, there were 65 (43.3%) individuals in the 30-39 age group, 39 (26.0%) in 
the 40-49 age group, and 46 (30.7%) in the ≥ 50 age group. More than 50 % of 
participants were females, and 82 % identified as being Mexican, Mexican-American, or 
Chicano. More than 70 % of participants were married or were part of an unmarried 
couple. When looking at the education level of participants, one-third reported having 
an elementary school education and one-third reported having a high school education. 
Interestingly, only 13 % of the study population reported having an education level 
higher than high school. More than 74 % of participants indicated that their household 
income is less than twenty-five thousand dollars.   
Table 1. Demographic characteristics of study sample  
Characteristics n (%) 
Age (years)  
30-39 65(43.3) 
40-49 39(26.0) 
≥50 46 (30.7) 
Gender  
Male 70(46.7) 
Female 80(53.3) 
Hispanic/Latino origin   
Mexican, Mexican-American, or Chicano 123(82.0) 
Central American 26(17.3) 
Other Latino, Hispanic, or Spanish origin 1(0.7) 
Marital status  
Married or unmarried couple 107(71.8) 
Divorced, separated, widowed, never married 42(28.2) 
Education (years)  
None 3(2.0) 
1-6 50(33.3) 
7-8 34(22.7) 
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Medical history 
The medical history of study participants is summarized in Table 2. Most 
participants indicated that their health status is good (36.0%) or fair (44.7%). 
Additionally, more than 67 % of participants reported not having any type of insurance 
to cover medical costs and only 36.7 % of participants had access to at least one 
personal doctor or health care provider at the time of the study. The cost associated 
with going to a primary care provider was identified as being an issue for 53 out of the 
150 study participants. Interestingly, more than 69 % of participants indicated that 
their last routine checkup with a doctor was within the past year. More than 69 % of 
participants indicated that within the last twelve months they have gone to a doctor, 
nurse, or other health professional to get care for themselves at least one time.  
For questions regarding colorectal cancer, only 2.7 % of participants indicated 
that they had been diagnosed with colorectal cancer or polyps. Furthermore, 5.3 % of 
participants stated that they had received a diagnosis of an inflammatory bowel disease 
such as Crohn’s disease or ulcerative colitis. Lastly, only 7.3 % of individuals marked 
that they had family history of colorectal cancer or polyps.  
9-12 50(33.3) 
>12 13(8.7) 
Income  
<15,000 58 (38.9) 
15,000-24,999 53 (35.6) 
≥25,000 38 (25.5) 
Table 2. Medical history of study sample  
Characteristics n (%)  
Health status     
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Knowledge and understanding 
The knowledge and understanding of colorectal cancer and associated screening 
tests is summarized in Table 3. Twenty-six percent of participants reported that they 
Excellent  8(5.3)  
Very good  11(7.3)  
Good  54(36.0)  
Fair   67(44.7)  
Poor  10(6.7)  
Insurance    
Yes  49(32.7)  
No  101(67.3)  
Access to a personal doctor  
     Yes, only one           45(30.0) 
     More than one           10(6.7) 
     No           95(63.3) 
Could not go to doctor due to cost    
Yes  53(35.3)  
No  96(64.0)  
Do not know/Not sure  1(0.7)  
Last routine check-up    
Never  12(6.7)  
< 1 year  103(69.1)  
between 1 and 2 years  11(7.4)  
between 2 and 5 years           11(7.4)  
> 5 years  12(8.1)  
Number of provider visits in previous year    
0  46(30.9)  
1  25(16.8)  
2-4  63(42.3)  
≥5  15(10.1)  
Been diagnosed with colorectal cancer or polyps    
Yes   4(2.7)  
No  145(96.7)  
Do not know/Not sure 1(0.7) 
Been diagnosed with an inflammatory intestinal disease    
Yes  8(5.3)  
No  139(92.7)  
Do not know/Not sure  3(2.0)  
Family history of colorectal cancer    
Yes  11(7.3)  
No  137(91.3)  
Do not know/Not sure  2(1.3)  
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had heard of a FOBT, while more than 53 % of participants indicated that they had 
heard of a colonoscopy. Approximately, 85 % of participants responded that a doctor 
has not advised them to do a FOBT and 80 % noted that a doctor has not advised them 
to undergo a colonoscopy. Only 12 % of participants have done a FOBT and 12.7 % 
have undergone a colonoscopy. Overall, most participants prefer undergoing a FOBT 
(52%) when compared to a colonoscopy (32.7%) or other type of test (8%). 
Interestingly, only 2 participants responded that they would prefer to not be tested for 
colorectal cancer.  
 
Table 3. Knowledge and understanding of colorectal cancer and 
colorectal cancer screening tests  
Characteristics n (%)  
Heard of FOBT     
Yes  39(26.0)  
No  109(72.7)  
Do not know/Not sure  2(1.3)  
Has a doctor advised you to undergo an FOBT   
Yes  21(14.0)  
No  127(84.7)  
Do not know/Not sure 2(1.3) 
Have you undergone an FOBT  
     Yes           18(12.0) 
     No           130(86.7) 
     Do not know/Not sure           2(1.3) 
Heard of a colonoscopy    
Yes  80(53.3)  
No  70(46.7)  
Has a doctor advised you to undergo a colonoscopy   
Yes 30(20.0)  
 No 120(80.0)  
Have you undergone a colonoscopy    
Yes 19(12.7)  
No 130(86.7)  
Do not know/Not sure 1(0.7) 
Test preference     
FOBT 78(52.0)  
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Colonoscopy  49(32.7)  
A different test  12(8.0)  
Do not want to be tested 2(1.3) 
Do not know/Not sure 9(6.0) 
 
We conducted a set of analyses to compare individuals that were below 50 years 
of age with those that were over 50 years of age, which is the screening age, and that 
did not report family history of CRC. Individuals that have reported family history of 
CRC would have been screened earlier, and for this reason they were excluded. In total 
we had 137 participants included in this analysis which is summarized in Table 4. One 
finding was that younger participants were less likely to have heard about FOBT and 
significantly less likely to have heard of colonoscopy (p = .0015) compared to older 
participants. People that were 50 years or older were significantly more likely to have 
had FOBT (p < .0001) and/or a colonoscopy (p < .0001) when compared to those that 
were 49 years or younger. Also, individuals 50 or older were significantly more likely to 
have been advised by a doctor to undergo an FOBT (9.5% vs 2.9%) (p < .0001) or a 
colonoscopy (13.9% vs 3.6%) (p < .0001) compared to individuals 30 to 49 years of 
age. 
Table 4. Knowledge and understanding of colorectal cancer screening tests for participants 30 
to 49 years vs participants 50 years or older  
Characteristics Age group ⱡ 
 30 to 49 (n = 137)  50 or older (n = 137)  p-values 
FOBT n(%) n(%)  
Heard of FOBT 21(21.6) 13(32.5) 0.1813 
   Ever had FOBT* 3(3.1) 11(27.5) < 0.0001 
Doctor advise FOBT* 4(2.9) 13(9.5) < 0.0001 
Colonoscopy    
Heard of 
colonoscopy* 
39(40.2) 28(70.0) 0.0015 
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Cognitive and environmental factors influencing colorectal cancer screening 
Percentages were calculated for cognitive factors and environmental factors 
regarding colorectal cancer and colorectal cancer screening tests. With regards to 
cognitive factors, only 14.9 % of participants were able to correctly state the screening 
initiation age for colorectal cancer (50 years old). Furthermore, there were differences 
when participants were asked how often people should do FOBT and how often people 
should do colonoscopies. More than 80 percent of the study population correctly stated 
that FOBT should be done on a yearly basis while only 10.7 percent correctly stated 
that a colonoscopy should be done once every ten years. We expanded upon these 
findings and compared knowledge of colorectal cancer guidelines according to age 
groups. Participants that were 50 or older were more likely to correctly guess how often 
to do FOBT and colonoscopy than participants that were 30 to 49 years old, but the 
differences were not significant. We were able to find significant differences (p = .0377) 
regarding the screening initiation age, and older individuals correctly guessed the 
screening initiation age 23.9 % of the time compared to younger individuals that 
correctly guessed the screening initiation age 10.8% of the time.  
 
Ever had 
colonoscopy* 
4(4.1) 11(27.5) < 0.0001 
Doctor advise* 
colonoscopy 
5(3.6) 19(13.9) < 0.0001 
ⱡ Participants with a family history of colorectal cancer were excluded    
  from both age groups  
* Differences between groups are statistically significant at the p <  
   0.05 level using Chi-square test 
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Percentages were calculated for cognitive factors and environmental factors 
regarding colorectal cancer and colorectal cancer screening tests as reported in Table 6. 
In the table we only included the percent of participants that indicated that they 
‘Agreed’ or ‘Strongly Agreed’ with the different statements for cognitive and 
environmental factors. All questions included in salience had more than 93 % of 
respondents indicating that they agreed with the statements. For the questions 
regarding fears, the percentage of participants that agreed with this statement varied 
from 27.3 % to 40 %. Susceptibility had more than 42 percent of participants in 
agreement with two questions and more than 70 % in agreement with the other two 
questions. For susceptibility the question that had the most people indicate that they 
‘Agree’ or ‘Strongly Agree’ was ‘I believe the chance I might develop colon cancer is 
Knowledge question 30 or older (n = 149)  ⱡ 
 Correct 
n(%) 
Incorrect 
n(%) 
Screening initiation age 22 (14.9) 126 (85.1) 
How often to do FOBT  120 (80.5) 29(19.5) 
How often to do colonoscopy  16 (10.7) 134 (89.3) 
 
Knowledge question Age groups 
 30 to 49 (n = 104)  ⱡ 50 or older (n = 46)  ⱡ  
 Correct 
n(%) 
Incorrect 
n(%) 
Correct 
n(%) 
Incorrect 
n(%) 
p-values 
Screening initiation age 11 (10.8) 91 (89.2) 11 (23.9)  0.0377 
How often to do FOBT 80 (77.7) 23 
(22.3) 
40 (87.0) 6 (13.0) 0.1859 
How often to do colonoscopy 9 (8.7) 95 (91.3) 7 (15.2) 39 (84.8) 0.2298 
* Differences between groups are statistically significant at the p < 0.05 level using   
   Chi-square test 
ⱡ Numbers may not add up due to participants not answering a question  
 
Table 5. Knowledge of colorectal cancer guidelines and comparisons by age 
groups 
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high’ with 71.3 %. Both questions in the screening efficacy category had more than 90 
% of participants that agreed with the statements. Self-efficacy had consisted of two 
questions that had more than 83 % agreement, one question with 30 % agreement, 
and one question with 43.3 % agreement. For knowledge more than 89 % of 
participants ‘Agreed’ or ‘Strongly Agreed’ for two questions. However, the question in 
knowledge that stated, ‘I believe that colon cancer is mainly a problem for men’ only 
had 51.3 agreement. For the question under social influence, there were two questions 
that had more than 86 % agreement, one question with 71.3 % agreement, and one 
question with 68 % agreement.  
Table 6. Percent distribution and mean scale scores for cognitive factors and environmental factors 
Cognitive 
factors 
Questions n(%)* Mean 
Salience Doing colon cancer testing makes sense to me. 147 (98.0)  
 
4.2 
I think the benefits of colon cancer testing outweigh any difficulty 
I might have in going through the test.  
140 (93.3) 
Going through colon cancer testing is an important thing for me 
to do. 
145 (96.7) 
I believe that having colon cancer testing can help to protect my 
health. 
149 (99.3) 
Fears I am afraid of having an abnormal test result.  58 (38.7)  
2.7 I am worried that testing will show that I have colon cancer.  41 (27.3) 
I am bothered by the possibility that testing might be physically 
uncomfortable.  
60 (40.0) 
Susceptibility I believe the chance I might develop colon cancer is high.  107 (71.3)  
3.3 I think it is very likely that I will develop colon cancer.  63 (42.0) 
I believe that the chance that I will develop polyps is high.  67 (44.7) 
I think that compared to other persons my age, I am at lower risk 
for colon cancer. 
105 (70.0) 
Screening efficacy I think that when colon polyps are found and removed, colon 
cancer can be prevented. 
135 (90.0)  
4.1 I believe that when colon cancer is found early, it can be cured. 148 (98.7) 
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Self-efficacy Arranging my schedule to go through colon cancer testing is an 
easy thing to do.  
138 (92.0)  
 
3.5 
Finding time to go through colon cancer testing would be difficult 
for me to do. 
65 (43.3) 
Going through colon cancer testing would be difficult for me to 
do.  
45 (30.0) 
I think that going through colon cancer testing would be an easy 
thing for me to do. 
124 (83.2) 
Knowledge I believe that colon cancer is mainly a problem for men.   77 (51.3)  
3.7 
I believe that a person could have colon cancer but not have any 
symptoms.  
134 (89.9) 
I think that getting checked regularly for colon cancer increases 
the chances of finding cancer when it’s easy to treat. 
140 (94.0) 
Environmental 
factor 
Questions   
Social influence I want to do what members of my immediate family think I should 
do about colon cancer testing.  
130 (86.7)  
 
3.8 
Members of my immediate family think I should go through colon 
cancer testing.  
107 (71.3) 
My doctor or health professional thinks I should have colon 
cancer testing.  
102 (68.0) 
I want to do what my doctor or health professional thinks I should 
do about colon cancer testing. 
138 (92.0) 
 
 
 
After calculating percentages, we calculated an overall mean score for salience, 
fears, susceptibility, screening efficacy, self-efficacy, knowledge, and social influence. 
With respect to cognitive factors, the mean for salience was 4.2, mean for fear was 2.7, 
mean for susceptibility was 3.3, mean for screening efficacy was 4.1, mean for self-
efficacy was 3.5, and mean for knowledge was 3.7. The mean score for social influence 
was 3.8. The cognitive factors and environmental factors were further studied in the 
context of three different independent variables. The three independent variables were 
age group, gender, and education level. These comparisons are summarized in Table 7. 
* Combining participants that selected Agree or Strongly Agree on a 5-point Likert Scale: 1 = strongly disagree, 2 = 
disagree, 3 = neither agree nor disagree 4 = agree, 5 = strongly agree 
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When cognitive and environmental factors were investigated in the context of age 
group there were no significant differences in the mean score between the groups for 
salience, fears, susceptibility, screening efficacy, self-efficacy, or knowledge. However, 
a significant difference was found between the factor of social influence and age group 
(p = .0105). The mean score for individuals in the 30 to 39 age group was 3.6 (SD = 
0.6), the mean score for individuals in the 40 to 49 age group was 3.7 (SD = 0.5), and 
the mean score for individuals in the 50 or older age group was 4.0 (SD = 0.4). These 
differences were further explored according to the questions that made up the 
environmental factor of social influence. These findings are summarized in Figure 4. 
Percentages for ‘Agree’ and ‘Strongly Agree’ were combined and displayed on the left 
side of the graph. Percentages for ‘Disagree’ and ‘Strongly Disagree’ were also 
combined and displayed on the right side of the graph. There were significant 
differences among the three age groups for the statement ‘Members of my immediate 
family think I should go through colon cancer testing (p = .0039).’ Eighty-seven percent 
of individuals 50 years or older agreed with this statement compared to 66.7 percent of 
individuals 40 to 49 years of age and 63.1 percent of individuals 30 to 39 years of age. 
There were also significant differences (p = .0123) for the statement ‘My doctor or 
health professional thinks I should have colon cancer testing.’ Older individuals were 
more likely to agree with this statement compared to younger individuals.  
With respect to gender there were no significant differences between males and 
females for the cognitive factors salience, fears, susceptibility, screening efficacy, or 
self-efficacy. Furthermore, there was also no significant difference for the 
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environmental factor of social influence. However, for the cognitive factor of knowledge 
there were significant differences (p = .0492) among the two gender groups. The mean 
score for males was 3.8 (SD = 0.5) and the mean score for females was 3.6 (SD = 0.6). 
These differences for the cognitive factor of knowledge between genders were further 
explored, and the findings are reported in Figure 5. Percentages for ‘Agree’ and 
‘Strongly Agree’ were combined and displayed on the left side of the graph. 
Percentages for ‘Disagree’ and ‘Strongly Disagree’ were also combined and displayed on 
the right side of the graph. More than 65 percent of males selected the response 
options of ‘Agree’ or ‘Strongly Agree’ to the question ‘I believe that colon cancer is 
mainly a problem for men.’ This is significantly (p = .004) higher when compared to the 
38.8 % of females who selected ‘Agree’ or ‘Strongly Agree’ for the same question. 
Finally, with regards to education level there was no significant difference for the 
cognitive factors of salience, fears, screening efficacy, self-efficacy, or knowledge. Also, 
there was no significant difference between the three different education level groups 
for the environment factor social influence. A significant difference was noted between 
the three different groups for the cognitive factor of susceptibility (p = 0.0006). The 
mean score for participants that had an education level of 6th grade or less was 3.6 (SD 
= 0.6), an education level of 7th to 8th grade was 3.3 (SD = 0.7), and an education level 
of 9th grade or higher was 3.1 (SD = 0.6). These differences are further explored in 
Figure 6. Percentages for ‘Agree’ and ‘Strongly Agree’ were combined and displayed on 
the left side of the graph. Percentages for ‘Disagree’ and ‘Strongly Disagree’ were also 
combined and displayed on the right side of the graph. There are three questions that 
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had significant differences according to education level. For the question ‘I believe the 
chance I might develop colon cancer is high’ more than 86 percent of participants with 
an education level of sixth grade or below selected ‘Agree’ or ‘Strongly Agree’ compared 
to 67.6 percent of participants with a seventh grade or eighth grade education level or 
60.3 percent of participants with an education level of high school or above (p = 
.0014). Approximately, fifty-seven percent of people with an education level of sixth 
grade or below selected ‘Agree’ or ‘Strongly Agree’ to the question ‘I think it is very 
likely that I will develop colon cancer’ compared to 38.2 percent of people with a 
seventh or eighth grade level or 31.7 percent of people with an education level of high 
school or above (p = .0104). Lastly, there were significant differences (p = .0062) for 
the question ‘I believe that the chance that I will develop colon polyps is high.’ Sixty 
four percent of people who had an education level of sixth grade or below agreed or 
strongly agreed compared to 52.9 percent and 27 percent for people who had an 
education level of seventh of eighth grade or individuals who had an education level of 
high school or above, respectively. All other figures comparing cognitive factors and 
environmental factors to the three variables of age group, gender, and education level 
are presented in Appendix part A. 
  
 Age group ⱡ 
 30 to 39 40 to 49 50 or 
older 
 
Factor mean, (std dev) p-values 
Salience 4.2 (0.4) 4.2 (0.4) 4.2 (0.4) 0.9367 
Fears 2.6 (0.8) 2.8 (0.8) 2.8 (0.8) 0.4572 
Table 7. Comparing barriers by age group, gender, and education 
level 
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Susceptibility 3.3 (0.7) 3.3 (0.7) 3.5 (0.6) 0.3104 
Screening efficacy 4.1 (0.5) 4.1 (0.4) 4.1 (0.4) 0.6162 
Self-efficacy 3.5 (0.4) 3.5 (0.4) 3.5 (0.4) 0.7478 
Knowledge 3.8 (0.5) 3.7 (0.6) 3.6 (0.6) 0.5063 
Social influence* 3.6 (0.6) 3.7 (0.5) 4.0 (0.4) 0.0105 
 Gender β 
 Male Female  
Factor mean, (std dev)  
Salience 4.2 (0.4) 4.2 (0.4) 0.5901 
Fears 2.8 (0.8) 2.6 (0.8) 0.2142 
Susceptibility* 3.4 (0.6) 3.2 (0.7) 0.0369 
Screening efficacy 4.1 (0.4) 4.1 (0.4) 0.2777 
Self-efficacy 3.5 (0.4) 3.5 (0.4) 0.3239 
Knowledge* 3.8 (0.5) 3.6 (0.6) 0.0492 
Social influence 3.8 (0.5) 3.6 (0.6) 0.5205 
 Education level ⱡ 
 6th grade 
or less 
7th – 8th 
grade 
9th grade 
or higher 
 
Factor mean, (std dev)  
Salience 4.2 (0.4) 4.2 (0.4) 4.2 (0.4) 0.8494 
Fears 2.6 (0.8) 2.8 (0.8) 2.8 (0.8) 0.1805 
Susceptibility* 3.3 (0.7) 3.3 (0.7) 3.5 (0.6) 0.0006 
Screening efficacy 4.1 (0.5) 4.1 (0.4) 4.1 (0.4) 0.6829 
Self-efficacy 3.5 (0.4) 3.5 (0.4) 3.5 (0.4) 0.7340 
Knowledge 3.8 (0.5) 3.7 (0.6) 3.6 (0.6) 0.5496 
Social influence 3.6 (0.6) 3.7 (0.5) 4.0 (0.4) 0.5067 
* Differences between groups are statistically significant at the p < 0.05 
ⱡ  Kruskal-Wallis test was utilized to look for significant differences 
β Wilcoxon Mann-Whitney test was utilized to look for significant differences 
 
 
 Figure 4. Older individuals rely more on social influence 
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                 *Differences between groups are statistically significant at the p < 0.05 
 
 
 
Figure 5. Misconception of men regarding colorectal cancer incidence by gender 
Figure 6. Misconception of perceived susceptibility in less-educated people 
*Differences between groups are statistically significant at the p < 0.05  
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    *Differences between groups are statistically significant at the p < 0.05 
 
Colorectal cancer screening test knowledge and awareness 
To compare the knowledge and awareness on colorectal cancer screening tests 
with the three independent variables a Chi-Square test of Independence was 
conducted. These findings are summarized in Table 8. When patients were asked if they 
had heard of a FOBT there were no significant differences between the three age 
groups. However, there were significant differences between the three age groups 
when they were asked if they ever had FOBT (p < 0.0001), heard of colonoscopy (p = 
0.0011), or ever had a colonoscopy (p < 0.0001). 32.6 % of people in the 50 and 
above age group have had FOBT while only 3.1 % people in the 30 to 39 age group 
and 2.6 % of people in the 40 to 49 group have had FOBT. For the colonoscopy 
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questions, more than 73 % of individuals aged 50 and above have heard of 
colonoscopy compared to 38.5 % of individuals aged 30 to 39 and 53.8 percent of 
individuals aged 40 to 49. For gender there were no significant differences for questions 
regarding FOBT or questions regarding colonoscopy. However, it does appear that there 
was a higher percentage of females (58.8%) who indicated that they had heard of 
colonoscopy compared to 47.1 % of males. When taking into consideration the 
education level of participants there were no significant differences for the questions 
regarding FOBT. For the questions regarding colonoscopy, there was a significant 
difference among the participants for whether they had heard of a colonoscopy (p = 
0.0523). More than 41 % of people who had an education of sixth grade or below 
reported having heard of colonoscopy compared to 41.5 % of people with an education 
level of seventh or eighth grade and 55.6 percent of people with an education level of 
high school or above.  
Table 8. Knowledge and preferences of CRC screening 
tests by age group, gender, and education level 
 
Age group ⱡ 
 30 to 39 40 to 49 50 and 
above 
p-values 
FOBT n(%)  
Heard of FOBT 15(23.1) 8(20.5) 16(34.8) 0.2537 
  Ever had FOBT* 2(3.1) 1(2.6) 15(32.6) <0.0001 
Colonoscopy     
 Heard of colonoscopy* 25(38.5) 21(53.8) 34(73.9) 0.0011 
 Ever had colonoscopy* 0(0.0) 5(12.8) 14(30.4) < 0.0001 
Gender β 
 Male Female  
FOBT n(%)  
Heard of FOBT 17(24.3) 22(27.5) 0.7113 
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*Differences between groups are statistically significant at the P < 0.05 level.  
ⱡ Chi-square test was utilized to look for significant differences 
β Fisher’s exact test was utilized to look for significant differences 
FOBT, fecal occult blood test 
 
Discussion 
The Latino population included in this study has limited access to some type of 
health insurance or coverage. This limited access is one reason for which many 
indicated that they do not have someone who they consider their personal doctor. 
However, one very interesting finding about this population is that they are still going to 
the doctor’s office for a routine check-up. In this study, more than 69 % of the 
participants indicated that they had seen a doctor or health professional for a routine 
check-up within the last year. Furthermore, almost 70 % of the study participants 
indicated that they had seen a provider at least once in the previous year. This finding 
is very informative because it indicates that although patients may not have health 
insurance or coverage, they are health conscious and hence there are still opportunities 
   Ever had FOBT 7(10.0) 11(13.8) 0.6162 
Colonoscopy    
   Heard of colonoscopy 33(47.1) 47(58.8) 0.1899 
Ever had colonoscopy 9(12.9) 10(12.5) 1.0000 
Education level  ⱡ 
 6th 
grade or 
below 
7th – 8th 
grade 
9th 
grade or 
above 
 
FOBT n(%)  
Heard of FOBT 10(18.9) 11(32.4) 18(28.6) 0.3118 
   Ever had FOBT 7(13.2) 6(17.6) 5(7.9) 0.3526 
Colonoscopy     
Heard of colonoscopy* 22(41.5) 23(67.6) 35(55.6) 0.0523 
Ever had colonoscopy 10(18.9) 5(14.7) 19(6.3) 0.1198 
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to have some sort of outreach for these patients regarding colorectal cancer and 
colorectal cancer screening.  
According to Eshghi et al. (2011), the cumulative colorectal cancer risk is about 5 
percent for the entire U.S. population. Furthermore, the CDC estimated that 1.3 percent 
of U.S. adults reported being diagnosed with an inflammatory bowel disease, either 
Crohn’s disease or ulcerative colitis (CDC, 2017a). Both of these estimates were not 
reported by ethnicity, so it is difficult to make comparisons with our study population. 
However, it should be noted that in our study population the reported cumulative 
colorectal cancer risk was lower at 2.7 percent. Additionally, this study population 
reported a much higher percent (5.3%) of having some type of IBD, such as Crohn’s 
disease or ulcerative colitis.  
When comparing the two tests FOBT and colonoscopy, it appears that more 
people have heard of a colonoscopy (53.3%) compared to FOBT (26.0%). This may be 
indicative of medical providers recommending colonoscopy more compared to FOBT. It 
may also indicate that patients are aware of other tests that may be able to detect 
colorectal cancer in the early stages such as fecal immunochemical test (FIT) or a 
sigmoidoscopy. One very interesting finding was that patients indicated that they prefer 
FOBT compared to a colonoscopy or other test. This could be because FOBT are done 
on a yearly basis, and many participants had the false impression that the more often 
you do the test the better it is for health. This is one misconception that needs to be 
addressed, so that patients are aware that the gold standard for colorectal cancer is 
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colonoscopy. Furthermore, only 14.9 percent of patients correctly identified the 
screening initiation age.  
When we compared individuals that were 50 or older with those that were 30 to 
49 we found significant differences for five out of the six questions regarding FOBT and 
colonoscopy. We learned that people who were 50 or older were more likely to have 
heard of FOBT and/or colonoscopy. Furthermore, they were more likely to have a 
doctor advise them to undergo either or both procedures. One final observation was 
that people that were 50 or older were more likely to follow through with undergoing 
FOBT or colonoscopy. These findings align with the finding reported in Table 5., that 
people who are 50 or older are significantly more likely to be aware of the screening 
initiation age compared to those in the 30 – 49 age range.  
For this study population the mean salience, using the Likert Scale of 1-5, was 
4.2. This mean indicates that participants scored slightly above ‘Agree’ to being aware 
about the benefits associated with getting screened for colorectal cancer and that this 
behavior is encouraged by significant others. The mean score for fear was 2.7, slightly 
below ‘Neither Agree nor Disagree’, which indicates that participants do not have 
negative perceptions towards undertaking and completing screening for colorectal 
cancer. With respect to susceptibility, the mean score was 3.3, slightly above ‘Neither 
Agree nor Disagree’, which indicates that these individuals are slightly aware of their 
personal risk of developing colorectal cancer or polyps. The mean score for screening 
efficacy was 4.1, and this score indicates that people ‘Agreed’ in the value of getting 
screened for colorectal cancer. Self-efficacy had a mean score of 3.5, which is in 
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between ‘Neither Agree nor Disagree’ and ‘Agree’, and this indicates that individuals are 
somewhat aware of the importance of getting screened for colorectal cancer. With 
respect to knowledge, the mean score was 3.7, which indicates that this study 
population answered slightly below ‘Agree’ about colorectal cancer knowledge. Finally, 
for the environmental factor of social influence the mean score was 3.8, and this 
indicates that most participants ‘Agree’ that interactions with members of their social 
network influences their colorectal cancer screening behavior.  
When the study population was divided into three age groups, there was only a 
significant difference for the environmental factor of social influence. Individuals in the 
age group 30 to 39 had a mean score of 3.6, individuals in the age group 40 to 49 had 
a mean score of 3.7, and the 50 or older age group had a mean score of 4.0. This 
difference may indicate that the older age group is more likely to be influenced by their 
interactions with members of their social network compared to the younger age groups. 
As indicated in Figure 4. the older age group selected ‘Agree’ or ‘Strongly Agree’ for the 
question ‘Members of my immediate family think I should go through colon cancer 
testing.’ This seems to indicate that older people have someone within their social 
network that is aware of the increased risk of developing colorectal cancer as an 
individual gets older. Furthermore, for the question ‘My doctor or health professional 
thinks I should have colon cancer testing’ 82.6 percent of the older age group selected 
‘Agree’ or ‘Strongly Agree’. This finding may indicate that the older age group is being 
made aware of their need to get screened for colorectal cancer by the provider that 
they are seeing. In this graph we can also see that as the age of an individual 
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decreases, then it is less likely that a provider will recommend colorectal cancer 
screening for them, which is expected.  
When the study population was divided into two gender categories, there was a 
significant difference for the cognitive factor of knowledge. Males had a mean score of 
3.8 and females had a mean score of 3.6. When this difference was further analyzed by 
looking at individual questions, there was a significant difference for the question ‘I 
believe that colon cancer is mainly a problem for men.’ More than 65 percent of males 
agreed or strongly agreed with this statement compared to only 38 percent of females. 
This finding may indicate that both males and females are not aware that colorectal 
cancer has the ability to affect any individual regardless of gender. However, it is 
extremely alarming that such a large proportion of males think that colorectal cancer is 
more likely to affect them. One possibility could be that males are confusing colorectal 
cancer with prostate cancer. This is definitely an issue that needs to be addressed, 
because this could be a potential reason for which individuals are not getting screened 
for this type of cancer.  
Finally, the study population was broken up into three different groups according 
to education level. There was a significant difference between the three different 
groups and the cognitive factor of susceptibility. People who were in the education level 
group of 6th grade or less had a mean score of 3.6, the 7th or 8th grade education level 
group had a mean score of 3.3, and the 9th grade or higher group had an education 
level of 3.1. Lower education groups think that their personal risk of developing 
colorectal cancer or polyps is higher compared to other groups, perhaps reflecting gaps 
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in health literacy among individuals with lower education. In the graph titled ‘Perceived 
Susceptibility by Education Level’ it can be noted that 86.8 percent of people with an 
education level of 6th grade or below were more likely to agree or strongly agree to the 
question ‘I believe the chance I might develop colon cancer is high’ compared to 60.3 
percent for the high school or above group and 67.6 percent for the seventh or eighth 
grade group. In the future analyses we will investigate if people with lower education 
level have more difficult time having access to health services or a primary care 
provider. If an individual does not see a provider on a regular basis, then it is very likely 
that they may not be aware of their health status and will be living in a state of 
uncertainty regarding colorectal cancer. For the question ‘I think it is very likely that I 
will develop colon cancer’ we see a very similar trend to the previous question. For the 
question ‘I believe that the chance that I will develop colon polyps is high we see a 
similar trend to the two previous questions. More than 60 percent of people with an 
education level of sixth grade or below agreed or strongly agreed compared to 52.9 
percent of people with a seventh grade or eighth grade education and 27 percent of 
people with a high school education or higher. One common trend among these three 
questions is that people with higher education levels are less likely to think that they 
will develop colorectal cancer or polyps. With this finding, out next analyses will be to 
look at if whether those individuals that reported higher level education also reported 
higher income. 
One limitation of this study is that it was only delivered to OneWorld patients, 
and this excluded individuals of Hispanic or Latino origin that do not seek services at 
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One World. These individuals may not have the financial means to seek any type of 
medical service or they may be seeking services at another clinic or hospital. Therefore, 
the results of this study may underestimate the lack of awareness of CRC and screening 
among Latinos. Furthermore, it is very likely that individuals that are not seeking 
medical services are less concerned about their health than those that are seeking 
medical services. We can expect to find even lower rates of colorectal cancer screening 
in the general Hispanic/Latino population that is not seeking out medical services.  
Another limitation of this study is that the results cannot be used to analyze 
behavior over a longer period. We cannot determine if knowledge, awareness, 
perception and attitudes increased after the survey was delivered to these 150 
individuals. Furthermore, we will not be able to look at the impact of the colorectal 
cancer educational materials that we disseminated to participants at the interview. 
Additionally, the timing of this cross-sectional study is not guaranteed to be 
representative. The data for this study was collected over the time frame of four 
months and the type of patients that receive medical services at One World may vary 
seasonally.  
Conclusions 
 In my opinion there are three important conclusions that can be made from this 
study. The first is that participants that are 50 years or older were more likely to agree 
that they have the social support to undergo colorectal cancer screening tests. This 
informs us that by reaching out to the social support system of these individuals we can 
also impact those that are due for screening. The second conclusion is that males have 
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a misconception that colorectal cancer is more likely to be a problem for men. Finally, 
we can conclude that people who have low education are more likely to agree that they 
are at a higher risk of developing colorectal cancer. This study enabled the identification 
of the current knowledge and awareness, perceptions, attitudes, and barriers to 
colorectal cancer screening among the Latino population in Omaha. Furthermore, in the 
process of collecting this information participants were educated about colorectal cancer 
and the screening tests associated with this type of cancer. Although we are dealing 
with a vulnerable population, it is quite clear that this population cares about their 
health and is willing to act as long as they have the necessary health education. 
Although this study had limitations, it was able to address some very important 
questions regarding colorectal cancer. There are two potential interventions that can 
help to increase CRC screening rates at OneWorld. The first intervention would be to 
make the switch from FOBT to FIT. Patients consider FIT to be a less-invasive test 
because it only requires one stool sample as compared to the three stool samples 
required by FOBT. Additionally, FIT does not require any diet restrictions, so patients 
are more likely to complete this test as compared to FOBT. The second intervention 
that I would recommend would be to engage in a FLUFIT or FLUFOBT campaign. The 
purpose of this campaign is to help increase screening rates by providing a take home 
FOBT or FIT to eligible patients when they receive their annual flu shot. 
FLUFIT/FLUFOBT is a research tested program that does not require many resources 
and has been proven to be well accepted by patients and lead to higher screening 
rates. This program will also allow for an opportunity to identify and reach out to all 
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individuals that are 50 years of age or older. Also, this campaign reinforces the CRC 
guidelines that FOBT/FIT must be completed on an annual basis. Future studies should 
incorporate a larger sample size and should evaluate why such a large proportion of 
males thought that colorectal cancer was mainly a problem for males.   
 
Reflection 
 
Impact of SL/CE at OneWorld 
It was a very unique experience being able to conduct my service 
learning/capstone experience (SL/CE) at OneWorld. I grew up in South Omaha, and I 
am aware of the tremendous impact that OneWorld has had on the health of the South 
Omaha community. This community health center provides an inviting environment that 
accommodates to the needs of the patients. For example, in the picture below we can 
see a ‘paletero’ in the front of the OneWorld building. The simple presence of the 
‘paletero’ is welcoming to Latino and Hispanic patients, and sends the message that 
they are about to walk into a friendly and understanding environment. Furthermore, 
when patients walk inside the building they are greeted with the mission of OneWorld 
which is, “OneWorld Community Health Centers, Inc., in partnership with the 
community, provide culturally respectful, quality health care with special attention to 
the underserved.” In some instances I was able to see the mission of OneWorld being 
put into practice. For example, I was able to see the transition of a patient from being 
uncomfortable to being comfortable once they learned that their doctor could speak 
their native language. 
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Many of the patients that seek medical services at OneWorld are from low 
socioeconomic status (SES) households, and this makes it difficult for them to find them 
affordable health services. However, at OneWorld, health services are delivered to 
patients in a much different manner. OneWorld has established a sliding fee scale 
system to ensure that health services are a right and not a privilege. Through this 
system patients must pay a certain percentage of medical expenses according to gross 
monthly income, and this expands on the number of services that can be offered to 
patients. Furthermore, OneWorld functions as a prevention oriented clinic in comparison 
to hospitals or other private clinics. They are aware that preventing a disease or 
diagnosing a disease in the early stages can financially help a patient. This money can 
be used by patients to buy food for their household, pay the monthly rent, or buy their 
children school supplies.  
Colorectal cancer project and service learning at OneWorld 
My project consisted of three different activities. The first activity involved 
carrying out a study titled ‘Awareness and attitudes of the Latino community in Omaha 
Gonzales  45 
 
on colorectal cancer and screening.’ This study had two different purposes which were 
(1) to investigate the awareness and attitudes of the Latino community in Omaha on 
colorectal cancer and screening tests and (2) to identify the barriers that prevent the 
Latino community in Omaha from undergoing cancer screening tests, specifically fecal 
occult blood test (FOBT) and colonoscopy. This study was possible through the 
collaboration of faculty at UNMC, the Nebraska chapter of American Cancer Society, and 
OneWorld Community Health Centers. As the picture below shows, I had set up a table 
at the lobby of the OneWorld building, and I was recruiting potential participants for the 
colorectal cancer study.  
  
The second activity involved identifying the most preferred media outlet for 
patients to receive information and education regarding CRC, and identifying the most 
effective message to encourage people to get screened for CRC. After delivering the 
survey we found that the most preferred media outlet was the community (church, 
supermarkets, hospitals, health fairs, community centers) and the most effective 
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message was ‘You are so important to your family, don’t let them down! Don’t 
procrastinate any longer! Get screened for colon cancer today! It could save your life.’  
The third activity involved calling approximately 178 patients that were at least 
50 years of age and were due for colorectal cancer screening. When these patients 
were called they were educated about the importance of undergoing CRC screening 
tests. Furthermore, they were offered three different types of tests which were FOBT, 
colonoscopy, or FIT. If a patient agreed to a certain type of screening test then it was 
mailed to their household, and a reminder call was given if the patient did not return 
the CRC screening test within 10 days. In the picture above, I was identifying OneWorld 
patients that were eligible for CRC screening through the electronic health records, and 
then called these patients.  
Professional Interactions at OneWorld 
During this project I was able to interact with individuals from various disciplines. 
Some of these disciplines included community navigators, health assistants, nurses, and 
physicians. Working at a FQHC was a great experience because I was able to witness 
multidisciplinary and interdisciplinary interactions. For example, for my project the 
nurse supervisor was able to introduce me to all of the staff, and this facilitated 
conducting my project. After I began to know the staff I was able to learn about the 
best practices to interact with the patients that seek services at OneWorld. This was 
essential due to the nature of my project, and the high likelihood that many participants 
would be too shy to complete the survey and provide feedback.  
Impact of project 
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This project impacted the community and target audience because people 
became aware of various things regarding CRC. For example, a large majority of the 
patients at OneWorld believed that CRC was predominantly a problem for men. This 
misconception could be preventing women from getting screened for this type of 
cancer. Also, a large proportion of the OneWorld community believed that getting 
screened for CRC every year (FOBT) was better than getting screened for CRC every 
ten years (colonoscopy). This finding shows that patients may not be aware of what 
tests are more effective at detecting CRC, and this could be a reason why people are 
unlikely to get a colonoscopy. Also, providing weekly reminders to patients so that they 
could return their FOBT and FIT kits was a very satisfying experience. The more times I 
called individuals it appeared that they began to appreciate that I was concerned about 
their health. People took the time to explain the various reasons for which they had not 
done the screening tests. Some of these reasons included not having the transportation 
to get to the clinic, finding the screening test gross, and even not wanting to know if 
they had CRC.  
Demonstrated competencies 
I was able to demonstrate the competencies for epidemiology and social and 
behavioral sciences. Through the navigation of the OneWorld electronic health records 
(EHR) I was able to identify principles and limitations of the CRC screening program. 
For example, staff were giving patients FOBT kits but were not following up with 
patients to ask them if they had a positive or negative test result. This was mainly due 
to the lack of communication between the staff lab at OneWorld that examines the 
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FOBT kits and the health assistants, nurses, and other providers who have to update 
the EHRs. For the social and behavior sciences, I was able to identify the causes of 
social and behavioral factors that affect health of individuals and populations. For 
example, a large majority of patients at OneWorld were not aware of the appropriate 
age to begin screening for CRC. Additionally, patients thought that CRC was 
predominantly a problem for men. I was able to demonstrate communication and 
informatics by being able to switch my communication styles for when I was 
communicating with patients and when I was communicating with OneWorld staff. This 
was important for engaging the patients because the majority of OneWorld patients 
have an educational level that is below high school, and this affects the health literacy 
of the patients. Finally, I demonstrated leadership by engaging in dialogue and learning 
from others in order to advance public health goals. This was primarily done through 
interactions with individuals in the Colorectal Cancer Task Force that was initiated by 
OneWorld. During meetings we would discuss the CRC screening rates and what we 
could do to increase these rates.  
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Appendix A: Likert graphs for questions regarding barriers to colorectal 
cancer and colorectal cancer screening.  
 
 
 
 
 
 
Figure 1 
The questions in these graphs were asked through a five-point version of the Likert 
Scale, which allowed respondents to indicate if they Strongly Agree, Agree, Neither 
Agree nor Disagree, Disagree, or Strongly Disagree with a question. We scored the 
five-point Likert Scale by assigning a value of 5 for Strongly Agree, a value of 4 for 
Agree, a value of 3 for Neither Agree nor Disagree, a value of 2 for Disagree, and a 
value of 1 for Strongly Disagree. In these graphs we grouped together the responses 
‘Agree’ and ‘Strongly Agree’ and reported them as percentages on the left side of the 
graphs. We also grouped together the responses ‘Disagree’ and ‘Strongly Disagree’ and 
reported them as percentages on the right side of the graphs. The response ‘Neither 
Agree nor Disagree’ was not grouped with any other response, and the percentage for 
this response is not reported in the graphs.  
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Appendix B: Colorectal cancer survey in English. 
 
Date:        Survey #:  
Colorectal Cancer Survey: Awareness and Attitudes of the Latino Community in 
Omaha on Colorectal Cancer and Screening Tests (IRB # 303-17-EX) 
This research study is being conducted by the University of Nebraska Medical Center 
College of Public Health and One World Community Health Centers as part of an effort 
to: (1) To investigate the awareness and attitudes of the Latino community in Omaha on 
colorectal cancer and screening tests and (2) To identify the barriers that prevent the 
Latino community in Omaha from undergoing colorectal cancer screening tests, 
specifically fecal occult blood test and colonoscopy. 
 
To participate in this study, you must be at least 30 years old and be of Latino or 
Hispanic origin.  
 
There is a total of 60 questions on this survey divided into 5 sections including: 
Demographics, Medical History, Knowledge and Awareness on Colorectal Cancer and 
Screening Tests, Perception and Attitudes on Colorectal Cancer and Screening Tests, and 
Barriers on Colorectal Cancer Screening.  
 
The survey will take approximately 15 to 20 minutes to complete and you will be 
compensated for your time after your completion of this survey.  
 
Your participation in this survey is completely voluntary. You may decline to participate, 
stop at any point during the survey, or skip any question you don’t wish to answer. Your 
responses will remain confidential and anonymous. If you have any questions or 
concerns about the research study please feel free to contact any of the study personnel 
listed below.  
 
Study team 
Roger Gonzales                                    Dr. Evi Farazi 
(402)578-9155                                     (402)559-5907 
roger.gonzales@unmc.edu                                    evi.farazi@unmc.edu 
 
Dr. Armando De Alba Rosales          Dr. Lynette Smith  
(402)559-3835             (402)559-8114 
armando.dealba@unmc.edu            lmsmith@unmc.edu 
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Dr. Hongmei Wang                         Dr. Jungyoon Kim 
(402)559-9413                          (402)552-7235 
hongmeiwang@unmc.edu            jungyoon.kim@unmc.ed 
Colorectal Cancer Questionnaire: 
“Awareness and attitudes of the Latino community in Omaha on colorectal cancer and 
screening tests” 
 
1. What is your age? ___________   (code age in years)  I’m not sure/I don’t know 
2. What is your gender?          Male     Female    Other: __________ 
3. Are you Latino, Hispanic, or Spanish origin?        Yes        No 
   3a. If “Yes”, ask: Are you…? 
    Mexican, Mexican American, or Chicano 
    Puerto Rican 
    Cuban 
    Central American 
    South American 
    Another Latino, Hispanic, or Spanish origin  
 
4. On a scale from zero to ten, please indicate your level of proficiency in speaking, 
understanding, and reading in the English language:  
Speaking  Understand 
spoken 
language 
 Reading  
 
5. Are you… ?  
 Married  Divorced  Widowed     Separated  Never married  
 A member of an unmarried couple 
 
6. What is the highest grade or year of school you completed? 
 Never attended school or only received preschool education 
 Grades 1 through 6 (Elementary) 
 Grades 7 through 8 (Middle school) 
 Grades 9 through 12 or diploma equivalent to baccalaureate (High school)  
 University or bachelor’s degree 
 Postgraduate university studies  
 
 
 
 
Demographic Questions 
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7. Is your annual household income from all sources…? 
 Less than $25,000 (if no go to $35,000)  
 Less than $20,000  
 Less than $15,000 
 Less than $10,000 
 Less than $35,000 (go here)  
 Less than $50,000  
 Less than $75,000  
 $75,000 or more  
 
 
8. Would you say that in general your health is: 
 Excellent    Very Good         Good     Fair         Poor    Don’t know/Not sure  
 
9. Currently, do you have some type of health care coverage?   Yes    No  
 
9a. If “Yes”, ask: Do you have …?  
 Private insurance 
 Public health insurance (Medicare or Medicaid)  
 Other type of health insurance: __________ 
 
9b. If “No”, ask: About how long has it been since you last had health care coverage?  
 6 months or less 
 More than 6 months, but not more than 1 year ago 
 More than 1 year, but not more than 3 years ago 
 More than 3 years 
 Never 
 Don’t know/Not sure 
 
10. Do you have one person you think of as your personal doctor of health care provider?  
 
10a. If “No,” ask: “Is there more than one, or is there no person who you think of as 
your personal doctor or health care provider?” 
 Yes, only one    More than one           No      Don’t know/Not sure 
 
11. Was there a time in the past 12 months when you needed to see a doctor but could not 
because of cost?  
 Yes    No    Don’t know/Not sure 
 
 
 
                                                                                       Medical History 
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12. About how long has it been since you last visited a doctor for a routine checkup? A routine 
checkup is a general physical exam, not an exam for a specific injury, illness, or condition. 
 Within the past year (anytime less than 12 months ago) 
 Within the past 2 years (1 year but less than 2 years ago)  
 Within the past 5 years (2 years but less than 5 years ago)  
 5 or more years ago  
 Don’t know/Not sure 
 Never  
 
13. In the last 12 months, not counting times you went to an emergency room, how many times 
did you go to a doctor, nurse, or other health professional to get care for yourself? 
 1 time   2 times   3 times   4 times   
 5-9 times    10 or more times  None    Don’t know/Not sure 
 
14. Has a doctor ever detected colon cancer or any polyps in your colon?    
 Yes            No         Don’t know/Not sure 
 
15. Has a doctor ever diagnosed you with an inflammatory bowel disease such as Crohn’s disease 
or ulcerative colitis?  
 Yes            No         Don’t know/Not sure 
 
16. Have any of your family members ever been diagnosed with colon cancer or had polyps in 
their colon? 
 Yes            No         Don’t know/Not sure 
 
16a. If the response is yes, was this family member a first-degree relative (parent, sibling, or child) 
or not a first degree relative (aunts, uncles, cousins)?  
 
 First-degree relative   Not a first-degree relative    Don’t know/Not sure 
 
The next questions are about tests for colon cancer. There are different kinds of tests for 
colorectal cancer. The first questions are about the fecal occult blood test (FOBT) for 
colorectal cancer.  
FOBT. A fecal occult blood test or stool blood test is a test to check for colorectal cancer. It is 
done at home using a set of 3 cards. You smear a sample of your fecal matter or stool on a card 
from 3 distinct bowel movements and return the cards to be tested for the presence of blood.  
                                          
17. Before this test was described, had you ever heard     Yes    
      of a fecal occult or stool blood test?       No 
                                   Knowledge and Awareness on Colorectal Cancer and Screening Tests 
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           Don’t know/Not sure 
 
18. In the last 12 months, did a doctor, nurse, or other     Yes 
       health professional advise you to do a stool blood test    No 
       using a “home” test kit?                                    Don’t know/Not sure 
 
19. Have you ever done a stool blood test using a “home”      Yes [Go to question 20] 
       test kit?             No [Go to question 23] 
   Don’t know/Not sure    
             [Go to question 23] 
 
20. How many home stool blood tests have you done in      0 
       the last 5 years?           1 
            2 
            3 
            4 
            5 
            5 or more 
                        Don’t know/Not sure 
 
21. When was your most recent home stool blood                  A year ago or less 
test?                     More than 1 but not 
                        more than 2 years ago 
   More than 2 but not       
        more than 5 years ago                                                                  
            More than 5 years ago 
            Don’t know/Not sure 
 
22. Why did you do your most recent home stool blood test?    Part of a routine exam or     
       check-up 
   Because of a symptom or 
                        health problem 
   Follow-up of an earlier 
     abnormal test  
   Don’t know/Not sure 
 
The next questions are about colonoscopy. Colonoscopy is a test that uses a narrow, lighted 
tube to examine the entire colon. With a colonoscopy, you are given medicine through a needle 
in your arm to make you sleepy, you need someone to drive you home, and you may need to 
take the rest of the day off from normal activities.  
 
23. Before this test was described, had you ever heard of      Yes 
       colonoscopy?          No 
            Don’t know/Not sure 
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24. In the last 12 months, did a doctor, nurse, or other health   Yes 
       professional advise you to get a colonoscopy?     No 
            Don’t know/Not sure 
      
 
25. Have you ever had a colonoscopy?        Yes [Go to question 26] 
                   No [Go to question 29] 
             Don’t know/Not sure 
          [Go to question 29] 
 
26. How many colonoscopy exams have you had in the last     0 
       10 years?           1 
            2    
            More than 2 
                        Don’t know/Not sure 
 
27. When was your most recent colonoscopy?     A year ago or less 
                     More than 1 but not 
                        more than 5 years ago 
   More than 5 but not       
        more than 10 years ago                                                                  
            More than 10 years ago 
            Don’t know/Not sure 
 
28. Why did you do your most recent colonoscopy?             Part of a routine exam or     
                         check-up 
   Because of a symptom or 
                        health problem 
   Follow-up of an earlier 
     abnormal test  
   Don’t know/Not sure 
 
 
The next questions ask what you think about colon cancer tests. 
29. Which colon cancer screening test would you most want  FOBT (fecal occult  
       to use if your doctor recommended you be tested for         test/stool blood test)  
       colon cancer             Colonoscopy 
             Other test:__________ 
   I would not want to be  
                       tested 
Perceptions and Attitudes on Colorectal Cancer and Screening Tests 
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            Don’t know/Not sure  
     
30. Which statement is closest to where you are now         I am not thinking of getting 
       in your plans to get tested for colon cancer?    tested for colon cancer 
                            I think I need to consider  
                               getting tested for colon cancer  
                I think I should get tested for   
                   colon cancer, but I am not  
                   ready 
                I think I will probably get  
                    tested for colon cancer 
                I am committed to getting  
                    tested for colon cancer 
 
31. What is the reason for your response if your                            I do not have health  
response was not ‘I am committed to getting tested                  insurance 
for colon cancer’?                                                                          I would rather not know if 
            I have colon cancer 
                       I think that the screening  
                    tests for colon cancer are  
                    disgusting or uncomfortable 
                     I do not have any symptoms  
           of colon cancer 
       I need more information   
          about the screening tests 
       I do not have time 
               Other: ________________ 
         ________________________ 
32. At what age are people supposed to start getting    
       tested for colon cancer?       _______________________ 
      (your best guess is fine)    
 
33. In general, once people start doing “home” stool blood     Once a year 
       tests for colon cancer, about how often should they      Every 5 years 
       should do them? (your best guess is fine)      Every 10 years  
            Only when there is a  
                problem 
   Other (specify) 
  _______________________ 
 
34. In general, once people start colonoscopy exams, about  Once a year 
       how often should they have them? (your best    Every 5 years 
       guess is fine)        Every 10 years  
          Only when there is a  
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              problem 
 Other (specify): ________ 
 
 
 
The next questions ask for your opinions about colon cancer and colon cancer testing. For 
each statement below, check whether you strongly agree, agree, neither agree nor disagree, 
disagree, or strongly disagree.    
 
Strongly  
Agree 
 
 
Agree 
Neither  
Agree Nor 
Disagree 
 
 
Disagree 
 
Strongly  
Disagree 
     
 
 
 
     
 
 
 
 
     
 
 
 
     
 
 
 
 
     
 
 
 
 
     
 
 
 
     
 
 
                                        Barriers on Colorectal Cancer Screening 
 
 
 
35. I believe the chance I might develop colon  
       cancer is high. 
 
 
36. Doing colon cancer testing makes sense to 
       me. 
 
 
37. Arranging my schedule to go through colon 
       cancer testing is an easy thing to do. 
 
 
38. I think the benefits of colon cancer testing 
      outweigh any difficulty I might have in doing  
      the tests.  
 
 
39. I want to do what members of my  
      immediate family think I should do about                 
      colon cancer. 
 
 
40. Going through colon cancer testing is an  
       important thing for me to do. 
 
 
41. I believe that having colon cancer testing can  
      help to protect my health. 
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Strongly  
Agree 
 
 
Agree 
Neither  
Agree Nor 
Disagree 
 
 
Disagree 
 
Strongly  
Disagree 
     
 
 
 
     
 
 
     
 
 
 
 
 
 
 
    
 
 
 
 
 
 
 
 
    
     
 
 
    
     
 
 
 
 
     
 
 
 
     
 
 
 
     
 
 
 
     
 
 
42. Finding time to go through colon cancer    
      testing would be difficult for me to do. 
 
 
43. I intend to undergo colon cancer testing. 
 
        
44. I am afraid of having an abnormal test   
      result. 
 
 
45. I think it is very likely that I will develop 
       colon cancer. 
 
 
46. I think that when colon polyps are found  
      and removed, colon cancer can be     
      prevented. 
 
 
47. Going through colon cancer testing would  
       be difficult for me to do.  
 
       
48. Members of my immediate family think I 
      should go through colon cancer testing.   
 
 
49. I am worried that testing will show that I  
      have colon cancer. 
 
 
50. I believe that the chance that I will develop  
      colon polyps is high. 
 
 
51. I am bothered by the possibility that testing  
      might be physically uncomfortable. 
 
 
52. I believe that when colon cancer is found  
      early, it can be cured. 
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Strongly  
Agree 
 
 
Agree 
Neither  
Agree Nor 
Disagree 
 
 
Disagree 
 
Strongly  
Disagree 
     
 
 
 
 
     
 
 
 
     
 
 
 
     
 
 
 
 
     
     
 
     
 
 
 
     
 
 
 
 
     
 
 
 
 
 
 
53. I think that going through colon cancer    
      testing would be an easy thing for me to  
      do.   
 
 
54. I think that compared to other persons  
       my age, I am at lower risk for colon cancer. 
     
 
55. My doctor or health professional thinks I  
      should have colon cancer testing. 
 
 
56. I want to do what my doctor or health 
      professional thinks I should do about colon 
      cancer testing. 
 
 
57. I believe that colon cancer is mainly a  
      problem for men. 
 
 
58. I believe that a person could have colon  
      cancer but not have any symptoms. 
  
      
59. I think that getting checked regularly for  
      colon cancer increases the chances of  
      finding cancer when it’s easy to treat.  
 
 
60. People should learn about colon cancer  
      tests in their 20s and 30s. 
 
 
 
Gonzales  79 
 
Which media outlet you would most prefer, so that you can receive colorectal cancer screening 
education and reminders? Rank the following items from 1 to 9, with 1 being the highest preference and 
9 being the lowest preference.  
Media outlet Rank 
Television (Univision and Telemundo, sports, novelas, medical shows, news)  
Internet (Facebook, Instagram, twitter, search engine, news feed)  
Community (churches, supermarkets, hospitals, health fairs, community centers)  
Text messaging   
Radio (97.7 radio Lobo, 102.3 El Patron)  
Newspaper (El Perico, Omaha World Herald)  
Photo novela  
Brochures  
Postcards through mail   
 
Which message do you think would be the most effective to get members of the Latino community to 
undergo colorectal cancer screening? Rank the following messages from 1 to 6, with 1 being the most 
effective message and 6 being the least effective message.  
 
Message Rank 
If you are 50 or older, you’re at a higher risk for colon cancer—even if you are 
healthy. Ask your doctor for a screening test. You can do a simple test at home. 
 
Colon cancer starts with a polyp in the large intestine. Polyps are very common in 
people age 50 and older, but they can be detected and removed before they turn 
into cancer. Don’t die of cancer. Talk to your doctor about colon cancer 
prevention. 
 
You are so important to your family, don’t let them down! Don’t procrastinate 
any longer! Get screened for colon cancer today! It could save your life.  
 
Colon cancer is the second leading cancer killer in the U.S. among Hispanics, but it 
doesn’t have to be. Colon cancer can be prevented or found at an early stage. 
Getting screened is absolutely necessary! Call a doctor today. 
 
Hi, my name is Maria.  I lost my father to colon cancer. He was too stubborn to 
get screened, but the cancer might have been prevented if he did. Don’t let your 
family lose you too.  Get screened and prevent colon cancer. 
 
Colon cancer is a silent killer! Many people with colon cancer do not have any 
symptoms or a family history. This is why screening is necessary even when you 
feel healthy.  Don’t wait until you have symptoms. 
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Appendix C: Colorectal cancer survey in Spanish.  
Fecha:        Cuestionario #:  
Cuestionario de Cáncer Colorrectal: Conocimiento y Actitudes de la Comunidad 
Latina en Omaha acerca del Cáncer Colorrectal y sus Pruebas Diagnósticas (IRB # 
303 – 17 – EX)  
Este estudio está siendo realizado por el Centro Médico de la Universidad de Nebraska, Colegio 
de Salud Pública y One World Centro de Salud Comunitario como parte de un esfuerzo para: (1) 
investigar la conciencia y las actitudes de la comunidad Latina en Omaha sobre el cáncer 
colorrectal y sus pruebas diagnósticas y (2) identificar las limitaciones que impiden que la 
comunidad Latina de Omaha se someta a exámenes de detección de cáncer colorrectal, 
específicamente análisis de sangre oculta en heces y colonoscopia. 
 
Para participar en el estudio, usted tiene que tener por lo menos 30 años y ser 
de origen Latino o Hispano. 
 
Hay un total de 60 preguntas en esta encuesta divididas en 5 secciones incluyendo: 
Demografías, Historial Médico, Conocimiento y Entendimiento del Cáncer Colorrectal  y 
sus Pruebas Diagnósticas, Percepciones y Actitudes Relacionadas al Cáncer Colorrectal y los 
Exámenes de Detección, y Limitaciones Para la Realización de Exámenes de Detección de 
Cáncer Colorrectal. 
 
La encuesta tomará aproximadamente 15 a 20 minutos para completar y usted será 
recompensado por su tiempo después de completar esta encuesta. 
 
Su participación en esta encuesta es completamente voluntaria. Puede negarse a participar, 
declinar por completo, detenerse en cualquier momento durante la encuesta u omitir cualquier 
pregunta que no desee responder. Sus respuestas serán confidenciales y anónimas. Si tiene 
alguna pregunta o inquietud sobre el estudio, no dude en comunicarlo a cualquier persona del 
estudio listada abajo. 
Equipo de Investigación 
Roger Gonzales                                    Dr. Evi Farazi 
(402)578-9155                                     (402)559-5907 
roger.gonzales@unmc.edu                                    evi.farazi@unmc.edu 
 
Dr. Armando De Alba Rosales          Dr. Lynette Smith  
(402)559-3835             (402)559-8114 
armando.dealba@unmc.edu            lmsmith@unmc.edu 
 
Dr. Hongmei Wang                         Dr. Jungyoon Kim 
(402)559-9413                          (402)552-7235 
hongmeiwang@unmc.edu            jungyoon.kim@unmc.edu 
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Cuestionario de Cáncer Colorrectal: 
“Conocimiento y Actitudes de la Comunidad Latina en Omaha acerca del Cáncer 
Colorrectal y sus Pruebas Diagnósticas” 
 
 
1. ¿Qué edad tiene?  ___________  (Codifique la edad en años)      No sabe/No está seguro/a 
 
2. ¿Cuál es su género?               Masculino      Femenino     Otro: ___________ 
 
3. ¿Es usted Latino/a, Hispano/a, o de origen Español?      Sí   No  
          
   3a. Si la respuesta es “Si” pregunte: ¿Es usted…?                        
    Mexicano/a, Mexicano-American/a, o Chicano/a  
    Puertorriqueño/a  
    Cubano/a 
    Centroamericano/a 
    Sudamericano/a 
    De otro origen Latino, Hispano, o Español 
 
4. En una escala de cero a diez, por favor indique su nivel de habilidad para hablar, entender y 
leer en el idioma inglés: 
Hablar  Entender 
lenguaje 
hablado 
 Leer  
 
5. ¿Es usted…?  
 Casado/a     Divorciado/a       Viudo/a      Separado/a  
Nunca estuvo casado/a     Vive en pareja sin estar casado/a 
 
6. ¿Cuál es el grado más alto o año de la escuela que completó? 
 Nunca fue a la escuela o solo recibió educación preescolar  
 De 1° a 6° grado (educación primaria) 
 De 7° a 8°grado (educación secundaria)  
 De 9° a 12° grado o diploma equivalente a Bachillerato (Preparatoria) 
 Universidad o Licenciatura 
 Estudios de postgrado universitario 
 
 
 
 
 
Preguntas demográficas  
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7. Tomando en cuenta todas sus fuentes de ingresos, los ingresos anuales de su hogar son:   
 Menos de 25,000 dólares (Si la respuesta es “No”, pregunte “Menos de 35,000 dólares”)  
 Menos de 20,000 dólares 
 Menos de 15,000 dólares 
 Menos de 10,000 dólares 
 Menos de 35,000 dólares (aquí) 
 Menos de 50,000 dólares 
 Menos de 75,000 dólares 
 75,000 dólares o más  
 
 
 
8. ¿Diría usted que su estado de salud general es…?: 
 Excelente    Muy Bueno     Bueno     Regular      Malo    No sabe/No está seguro/a 
 
9. Actualmente, ¿tiene algún tipo de seguro o cobertura de gastos médicos?           Sí    No 
 
9a. Si la respuesta es “Si” pregunte: ¿Es este seguro…?            
 Privado  
 Público (Medicare, Medicaid)  
 Otra cobertura: __________________________  
 
9b. Si la respuesta es “No” pregunte: ¿Cuánto hace que no tiene seguro de gastos médicos?           
 Hace 6 meses o menos 
 Hace más de 6 meses, pero menos de 1 ano 
 Hace más de 1 ano, pero menos de 3 anos 
 Hace más de 3 anos 
 Nunca 
 No sabe/No está seguro/a 
 
10. ¿Hay alguna persona a la que usted considere su médico de cabecera o proveedor de atención 
medica personal? 
 Sí, solo uno     Más de uno         No       No sabe/No está seguro/a 
 
11. En los últimos 12 meses, ¿hubo algún momento en que necesitó ver a un médico, pero no 
pudo hacerlo por razones económicas?  
 Sí   No    No sabe/No está seguro/a 
 
 
 
 
 
 
 
                                                                                       Historial médico 
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12. ¿Aproximadamente, cuándo fue la última vez que fue al médico para hacerse un 
chequeo de rutina? Un chequeo de rutina es un examen físico general, que no se realiza  
por una lesión, enfermedad o afección específica. 
 En el último año (hace menos de 12 meses) 
 En los últimos 2 años (hace 1 año, pero menos de 2) 
 En los últimos 5 años (hace 2 años per menos de 5) 
 Hace 5 años o mas  
 Nunca 
 No sabe/No está seguro/a  
 
13. En los últimos 12 meses, sin contar las veces que fue a una sala de emergencias, ¿cuántas 
veces fue a un médico, enfermera u otro profesional de la salud para recibir atención médica? 
 1 vez   2 veces   3 veces   4 veces   
 5-9 veces    Nada   No sabe/No está seguro/a 
 
14. ¿Alguna vez algún médico le ha detectado cáncer de colon o algún pólipo (adenomatoso) en 
su intestino?          
 Sí             No             No sabe/No está seguro/a 
 
15. ¿Alguna vez algún médico le ha diagnosticado que tiene una enfermedad intestinal 
inflamatoria como enfermedad de Crohn o colitis ulcerosos? 
 Sí             No             No sabe/No está seguro/a 
  
16. ¿Alguna vez le han diagnosticado a un familiar de usted cáncer de colon o algún pólipo en su 
intestino?  
 Sí             No             No sabe/No está seguro/a 
 
16a. Si la respuesta fue sí, ¿fue esta persona un familiar directo (padres, hermanos, hijos) o un 
familiar lejano (tíos, primos)?  
 Familiar directo   Familiar lejano                  No sabe/No está seguro/a 
 
Las siguientes preguntas están relacionadas a las pruebas para diagnosticar el cáncer de 
colon. Existen diferentes tipos de exámenes para detectar el cáncer de colon. Las primeras 
preguntas son acerca del examen de sangre oculta en heces 
El examen de sangre oculta en heces es un estudio que se realiza para detectar la presencia de 
sangre mezclada en la materia fecal o excremento. En casa, el paciente coloca una muestra 
pequeña de materia fecal en un tubo recolector especial o en tarjetas especiales (tres tarjetas). 
En el caso de las tarjetas especiales, se toman muestras de tres evacuaciones distintas y se 
envían de regreso al doctor o al laboratorio para su análisis.  
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17. Antes de que le describiera este examen, ¿alguna vez     Sí    
      había usted escuchado de algún examen de sangre    No 
      oculta en heces?         No sabe/No está seguro/a 
 
18. ¿En los últimos 12 meses, algún médico, enfermero u   Sí 
       otro profesional de la salud le ha aconsejado que se haga  No 
       un examen de sangre oculta en heces usando un paquete/         No sabe/No está seguro/a  
       instrumentos para tomar la prueba en casa? 
 
 
19. ¿Alguna vez se ha hecho un examen de sangre oculta en    Sí [Ir a la pregunta 20] 
       heces usando un paquete/instrumentos para tomar la      No [Ir a la pregunta 23] 
       prueba en casa?          No sabe/No está seguro/a 
               [Ir a la pregunta 23] 
 
20. Usando la prueba casera, ¿Cuántos exámenes de sangre   0 
       oculta en heces se ha hecho en los últimos 5 años?    1 
           2 
           3 
           4 
           5 
           5 o más 
                       No sabe/No está seguro/a 
 
21. Usando la prueba casera ¿Cuándo fue su examen mas     Hace un año o menos 
reciente de sangre oculta en heces?          Más de 1 pero no más de  
                 2 años atrás 
  Más de 2 pero no más de  
      5 años atrás 
           Hace más de 5 años 
           No sabe/No está seguro/a 
 
 
 
 
22. ¿Cuál es la razón por la cual se hizo su examen mas      Parte de un examen de      
        reciente de sangre oculta en heces?           rutina o revisión 
   Debido a un síntoma o  
                        problema de salud 
   Seguimiento de una  
       prueba anormal anterior  
   No sabe/No está   
      seguro/a 
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Las siguientes preguntas son en relación al examen de colonoscopía. La colonoscopía es un 
procedimiento que utiliza un tubo largo, flexible y delgado, con una luz y una pequeña cámara 
en un extremo para ver el interior del recto y todo el colon. Cuando se hace una colonoscopía, 
al paciente se le administra medicamento inyectado en la vena para que le de sueño. El 
paciente necesita que alguien lo lleve a su casa, y quizás necesite tomar el resto del día libre de 
sus actividades normales. 
 
23. Antes de que le describiera este examen, ¿alguna vez      Sí 
       había usted escuchado del examen de la colonoscopía?   No 
           No sabe/No está seguro/a 
 
24. En los últimos 12 meses, ¿algún médico, enfermero       Sí 
       u otro profesional de la salud le ha aconsejado que    No 
       se haga una colonoscopía?        No sabe/No está seguro/a 
      
 
25. ¿Alguna vez se ha realizado una colonoscopía?      Sí [Ir a la pregunta 26] 
                  No [Ir a la pregunta 29] 
            No sabe/No está seguro/a 
               [Ir a la pregunta 29] 
 
26. ¿Cuántos exámenes de colonoscopía se ha hecho    0 
       en los últimos 10 años?        1 
           2    
           Más de 2 
                       No sabe/No está seguro/a 
 
27. ¿Cuándo fue su colonoscopía más reciente?     Hace un año o menos 
                    Más de 1 pero no más 
                       de 5 años atrás 
  Más de 5 pero no más de  
      10 años atrás                                                              
           Hace más de 10 años 
           No sabe/No está seguro/a  
 
28. ¿Cuál es la razón por la cual se realizó su colonoscopía              Parte de un examen de  
más reciente?                                                                                              un examen de rutin a o 
       chequeo 
   Debido a un síntoma o 
       problema de salud 
   Seguimiento de una 
       prueba anormal anterior 
   No sabe/No está  
       seguro/a 
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 Las siguientes preguntas son relacionadas a lo que usted piensa de los exámenes para 
diagnosticar el cáncer de colon. 
29. ¿Qué examen diagnostico preferiría usted si su médico   SOH (examen de sangre 
       le recomendara hacerse una prueba para detectar el         oculta en heces)       
       cáncer de colon?         Colonoscopia 
           Otro examen: _________ 
 No quisiera ser     
     examinado 
          No sabe/No está seguro/a  
    
30. ¿Cuál de las siguientes afirmaciones refleja  No estoy pensando en hacerme el 
de mejor manera sus planes para realizarse      examen de cáncer de colon 
un examen de diagnóstico de cáncer de   Creo que debo considerar hacerme  
       colon?                    el examen de cáncer de colon 
 Creo que debería hacerme el examen de 
     cáncer de colon, pero no estoy listo 
        Creo que probablemente me hare el 
            examen de cáncer de colon 
        Estoy decidido(a) a hacerme el 
examen de diagnóstico de cáncer de 
colon 
 
31. Si su respuesta no fue: “Estoy decidido(a)            No tengo seguro de salud 
a hacerme el examen de cáncer de colon”,         Prefiero no saber si tengo cáncer de colon 
 ¿cuál fue la razón?                                                   Creo que los exámenes de detección de 
                                            cáncer de colon son asquerosas y/o 
    incomodos    
             No tengo ningún síntoma de cáncer de  
     colon  
             Necesito más información sobre los   
exámenes de detección de cáncer de 
colon 
             No tengo tiempo  
                   Otra: _____________________________ 
        ______________________________ 
 
32. ¿A qué edad considera que las personas deben   ______________________________ 
       comenzar a hacerse un examen para detectar el  
       cáncer de colon? 
       (cualquier intento de adivinar es bienvenido) 
Percepciones y Actitudes Relacionadas al Cáncer Colorrectal y los Exámenes de Detección  
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33. Una vez que las personas comienzan a hacerse los exámenes    Una vez al año 
       de sangre oculta en heces para detectar el cáncer de colon,     Cada 5 años 
       ¿con qué frecuencia creé usted que estas personas tengan     Cada 10 años 
       que volver a hacerse este examen?         Solo cuando hay un 
       (cualquier intento de adivinar es bienvenido)          problema 
   Otra (especificar) 
  _______________________ 
 
34. Una vez que las personas comienzan a hacerse los exámenes    Una vez al año 
       de colonoscopia, ¿con qué frecuencia creé usted que estas    Cada 5 años 
      personas tengan que volver a hacerse este examen?      Cada 10 años 
      (cualquier intento de adivinar es bienvenido)      Solo cuando hay un  
       problema 
   Otra (especificar) 
  _______________________ 
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En  
Desacuerdo 
 
Muy en 
Desacuerdo  
     
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     
 
 
 
 
     
 
 
 
 
 
     
 
 
 
 
 
     
 
 
 
 
     
 
 
 
 
 
35. La posibilidad de que desarrolle 
      cáncer de colon es alta.  
 
 
 
36. Comprendo la importancia de  
      realizarme pruebas de detección de  
      cáncer de colon 
 
 
 
37. Puedo organizar fácilmente mí tiempo  
      para realizarme un examen de  
      diagnóstico de cáncer de colon.  
 
 
38. Al hacerme el examen de diagnóstico  
      de cáncer de colon, creo que los  
      beneficios son mayores que los riesgos.  
 
 
 
39. Quiero seguir las recomendaciones que  
      los miembros cercanos de mi familia  
      me dan acerca del cáncer de colon.  
 
 
 
40. Es importante para mi realizarme el  
      examen de diagnóstico de cáncer de  
      colon.  
 
41. Creo que realizarme el examen  
diagnóstico de cáncer de colon puede 
ayudar a proteger mi salud.  
                                       Limitaciones Para la Realizacion de Examenes de Detección de Cáncer Colorrectal  
 
Las siguientes preguntas piden sus opiniones sobre cáncer de colon y examines de cáncer de colon. Para cada 
declaración marque si está en muy de acuerdo, de acuerdo, ni de acuerdo ni en desacuerdo, en desacuerdo, o muy en 
desacuerdo.  
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     
 
 
 
42. Es difícil para mí organizar mi tiempo para 
      realizarme un examen de diagnóstico de  
      cáncer de colon.  
 
 
43. Tengo la intención de someterme a 
       un examen de diagnóstico de cáncer de 
      colon.   
        
44. Tengo miedo de que el resultado de mi  
      examen de diagnóstico no sea normal.   
 
 
45. Creo que es muy probable que desarrolle  
      cáncer de colon.  
 
 
46. Considero que cuando hay pólipos en el  
colon y estos se extirpan, el cáncer de 
colon se puede prevenir.  
 
 
47. Sería difícil para mí realizarme un examen  
      de diagnóstico de cáncer de colon.  
 
       
48. Los miembros cercanos de mi familia  
      piensan que debo realizarme el examen de  
      diagnóstico de cáncer de colon.  
 
 
49. Me preocupa que el examen de  
      diagnóstico demuestre que tengo cáncer  
      de colon.  
 
 
50. Creo que la probabilidad de que desarrolle  
       pólipos en el colon es alta.  
 
 
51. Me molesta la posibilidad de que el  
      examen de diagnóstico de cáncer de colon 
      sea físicamente incomodos.  
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52. Creo que cuando el cáncer de colon es  
      diagnosticado en una etapa temprana, es  
      curable.  
 
 
53. Es fácil para mi realizarme un examen de  
      diagnóstico de cáncer de colon.  
 
 
54. Creo que en comparación con otras 
       personas de mi edad, tengo un menor 
      riesgo de padecer cáncer de colon.  
     
 
55. Mi médico o proveedor de salud    
      considera que debería someterme a un    
     examen de diagnóstico de cáncer de    
     colon.  
 
56. Quiero seguir las recomendaciones que  
      mi médico o proveedor de salud me dan    
      para detectar el cáncer de colon.  
 
 
57. Creo que el cáncer de colon es  
       principalmente un problema para los       
       hombres. 
 
 
58. Creo que una persona podría padecer  
      cáncer de colon, sin presentar ningún  
      síntoma.   
 
      
59. Considero que realizarse chequeos  
      regulares aumenta la posibilidad de    
      diagnosticar el cáncer de colon en  
     etapas en las que fácilmente se pueda   
     tratar.  
 
 
60. La gente que está en sus años 20 y 30  
     debería conocer acerca de los exámenes  
     de diagnóstico de cáncer de colon.   
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¿Qué medio de comunicación prefiere para recibir educación y avisos sobre la detección de cáncer 
colorrectal? Clasifique los siguientes medios de comunicación del 1 al 9. Use el 1 para el medio de 
comunicación que más prefiere y el 9 para el medio de comunicación que menos prefiere.  
Medio de comunicacion Rank 
Televisión (Univision y Telemundo, deportes, novelas, programas médicos, noticias)  
Internet (Facebook, Instagram, Twitter, noticias)  
Comunidad (iglesias, supermercados, hospitales, ferias de salud, centros comunitarios)  
Mensaje de texto   
Radio (97.7 radio Lobo, 102.3 El Patron)  
Periodico (El Perico, Omaha World Herald)  
Fotonovela  
Folletos  
Tarjeta postal a través del correo   
 
¿Qué mensaje cree usted que sería más efectivo para que los miembros de la comunidad Latino se 
sometan a un examen de detección de cáncer colorrectal? Clasifique los siguientes mensajes del 1 al 6. 
Use el 1 para el mensaje que sería más efectivo y el 6 para el mensaje que sería menos efectivo.  
 
Mensaje Rank 
Si tienes 50 años o más, estás en un mayor riesgo del cáncer de colon, incluso si te sientes 
saludable. Pide a tu médico una prueba de detección. Puedes hacer una prueba simple en 
tu casa. 
 
El cáncer de colon comienza con un pólipo en el intestino grueso. Los pólipos son muy 
comunes en las personas mayores de 50 años, pero pueden ser detectados y eliminados 
antes de que se conviertan en cáncer. No muera de cáncer. Hable con su médico sobre la 
prevención del cáncer de colon 
 
Tú eres muy importante para tu familia, ¡no los defraudes! ¡Ya no demores esto! ¡Hazte 
un examen de detección de cáncer de colon hoy mismo! Puede salvar tu vida. 
 
El cáncer de colon es la segunda causa de fallecimientos por cáncer entre los hispanos de 
EE. UU., ¡pero es algo que se puede evitar! El cáncer de colon se puede prevenir o 
detectar en sus etapas tempranas. ¡Es absolutamente necesario que te hagas un examen 
de detección! Llama al médico hoy mismo. 
 
Hola, me llamo María. Perdí a mi padre a causa del cáncer de colon. Él era demasiado 
testarudo para hacerse una prueba de detección, pero el cáncer pudo haber sido 
prevenido si lo hubiese hecho. No dejes que tu familia también te pierda. Hazte una 
prueba de detección y previene el cáncer de colon. 
 
¡El cáncer del colon es un asesino silencioso! Muchas personas con cáncer del colon no 
presentan ningún síntoma ni tienen antecedentes en su familia. Por esto los exámenes de 
detección son necesarios aunque pienses que estás sano. No esperes hasta que tengas 
síntomas. 
 
 
 
